WO2005085317A1 - Ultraviolet-curing composition - Google Patents

Ultraviolet-curing composition Download PDF

Info

Publication number
WO2005085317A1
WO2005085317A1 PCT/JP2005/003351 JP2005003351W WO2005085317A1 WO 2005085317 A1 WO2005085317 A1 WO 2005085317A1 JP 2005003351 W JP2005003351 W JP 2005003351W WO 2005085317 A1 WO2005085317 A1 WO 2005085317A1
Authority
WO
WIPO (PCT)
Prior art keywords
formula
integer
group
compound
carbon atoms
Prior art date
Application number
PCT/JP2005/003351
Other languages
French (fr)
Japanese (ja)
Inventor
Kazumasa Inata
Nobuaki Koike
Original Assignee
Toagosei Co., Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Toagosei Co., Ltd. filed Critical Toagosei Co., Ltd.
Priority to KR1020067020105A priority Critical patent/KR101111372B1/en
Priority to JP2006510668A priority patent/JP4548415B2/en
Publication of WO2005085317A1 publication Critical patent/WO2005085317A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G59/00Polycondensates containing more than one epoxy group per molecule; Macromolecules obtained by polymerising compounds containing more than one epoxy group per molecule using curing agents or catalysts which react with the epoxy groups
    • C08G59/18Macromolecules obtained by polymerising compounds containing more than one epoxy group per molecule using curing agents or catalysts which react with the epoxy groups ; e.g. general methods of curing
    • C08G59/40Macromolecules obtained by polymerising compounds containing more than one epoxy group per molecule using curing agents or catalysts which react with the epoxy groups ; e.g. general methods of curing characterised by the curing agents used
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G59/00Polycondensates containing more than one epoxy group per molecule; Macromolecules obtained by polymerising compounds containing more than one epoxy group per molecule using curing agents or catalysts which react with the epoxy groups
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08LCOMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L101/00Compositions of unspecified macromolecular compounds
    • GPHYSICS
    • G02OPTICS
    • G02BOPTICAL ELEMENTS, SYSTEMS OR APPARATUS
    • G02B1/00Optical elements characterised by the material of which they are made; Optical coatings for optical elements
    • G02B1/04Optical elements characterised by the material of which they are made; Optical coatings for optical elements made of organic materials, e.g. plastics

Definitions

  • the present invention relates to a cation-curable ultraviolet-curable composition suitable as a display such as a liquid crystal display, a plasma display, and a touch panel, and an optical material such as an optical lens that requires transparency.
  • the present invention relates to a novel biphenyl derivative having an oxetane ring capable of cationic polymerization and a method for producing the same.
  • An ultraviolet curable composition is widely used as an optical material because of its features such as excellent productivity and easy application of a cured product having a fine shape.
  • a UV curable composition is poured into a mold having fine irregularities, covered with a transparent plastic substrate, cured by irradiating UV rays, and cured.
  • the ultraviolet-curable composition is also used as a binder for a diffusion sheet or a material for bonding various films.
  • UV curable compositions Most of the raw materials of the ultraviolet curable composition are acrylic compounds, and acrylic compounds occupy most of the optical applications as described above.
  • various types of optical members and methods for producing the same have been devised using ultraviolet-curable compositions, and accordingly, strict performance is required for ultraviolet-curable compositions.
  • UV curable compositions On the other hand, there are demands for a conventional acrylic compound having good adhesion to a substrate which is difficult to adhere to, a material having a low shrinkage upon curing, and a material having a low water absorption.
  • the cationically curable composition using the epoxy conjugate compound and the oxetane conjugate compound has better and better performance in terms of these physical properties than the acrylic compound.
  • Oxetane conjugates are compounds that have attracted attention in recent years as monomers that can be cured by cationic polymerization or the like, and many oxetane conjugates have been reported.
  • a bisoxetane ether conjugate obtained by contacting a 3-alkyl 3-hydroxymethyloxetane with an ⁇ , ⁇ -dibumoalkane in the presence of an aqueous alkali metal hydroxide solution and a phase transfer catalyst has been reported.
  • Non-Patent Document 1 Non-Patent Document 1
  • R—R represents a hydrogen atom or a methyl group
  • R and R represent a hydrogen atom or
  • the cationically curable composition includes a cationically polymerizable conjugate, which is an epoxy conjugate or a Z or oxetane conjugate, a glycidyl group or a 3-ethyl-3,3-xentanylmethyl group having an ether bond.
  • a cationically polymerizable conjugate which is an epoxy conjugate or a Z or oxetane conjugate, a glycidyl group or a 3-ethyl-3,3-xentanylmethyl group having an ether bond.
  • An aromatic etherified compound such as phenylene and naphthalene, and a photo-thione curable composition containing a photo-thione initiator have been reported (for example, see Patent Document 9). .
  • a transmission type characterized by containing a bisphenol type epoxy (meth) acrylate and / or urethane (meth) acrylate, a vinyl ether conjugate, a photodynamic thione polymerization initiator and a photoradical polymerization initiator.
  • An ultraviolet curable composition for a screen has been reported (for example, see Patent Document 10).
  • a polymerizable conjugate in which 5-95% of epoxy groups in the epoxy compound are (meth) acryloyl and 5-60% of hydroxyl groups in Z or phenoxy resin are a, ⁇ -unsaturated monoisocyanate.
  • Patent Document 1 JP-A-6-16804
  • Patent Document 2 German Patent No. 1021858
  • Patent Document 3 JP-A-7-53711
  • Patent Document 4 JP-A-7-173279
  • Patent Document 5 JP-A-8-245783
  • Patent Document 6 JP-A-9-309950
  • Patent Document 7 JP-A-10-212343
  • Patent Document 8 JP 2001-31665 A
  • Patent Document 9 JP-A-2003-096184
  • Patent Document 10 JP-A-07-199359
  • Patent Document 11 JP 2001-163939 A
  • Non-patent Document l Bull.Chem.Soc.Jpn., 61, pp. 1653 (1989)
  • Non-Patent Document 2 Pure Appl.Chem., A29 (10), pp. 915 (1992)
  • Non-Patent Document 3 Pure Appl.Chem., A30 (2 & 3), pp. 189 (1993)
  • the problem to be solved by the present invention is to provide a resin having a small yellowing that can be used for optical applications where colorless and transparent properties are strictly required. And a method for producing the same.
  • an ultraviolet-curable composition comprising at least one compound represented by the following formula (1), a compound A having two or more cationically polymerizable groups, and a photoactive thione polymerization initiator;
  • R 1 represents a hydrogen atom or a methyl group
  • n represents an integer of 0 to 20
  • B represents an alkyl group having 1 to 16 carbon atoms, and an alkoxy group having 1 to 16 carbon atoms.
  • the number L of substituents of B represents an integer from 0 to 5
  • the number m of substituents of B represents an integer from 0 to 4
  • Z represents the following formula (2) or the following formula: (Represents (3).)
  • R 2 represents a hydrogen atom or an alkyl group having 116 carbon atoms.
  • R 3 represents a hydrogen atom or a methyl group.
  • R 1 represents a hydrogen atom or a methyl group
  • R 2 represents a hydrogen atom or an alkyl group having 1 to 16 carbon atoms
  • n represents an integer of 0 to 20
  • B represents a carbon number. It represents an alkyl group of 1 to 6, an alkoxy group of 1 to 6 carbon atoms, or a halogen atom
  • the number of substituents of B represents an integer of 0 to 5
  • the number of substituents of B is an integer of 0 to 4.
  • a force-thione curable composition containing a compound represented by the formula (4) according to (8) and a cationic polymerization initiator
  • a method for producing a compound represented by the formula (7) which comprises reacting a compound represented by the formula (5) with a compound represented by the formula (6) in the presence of an alkali. is there.
  • R 1 represents a hydrogen atom or a methyl group
  • n represents an integer of 0 to 20
  • B represents an alkyl group having 16 carbon atoms
  • B represents an alkyl group having 11 carbon atoms.
  • 6 represents an alkoxy group or a halogen atom
  • the number of substituents L of B represents an integer from 0 to 5
  • the number of substituents m of B represents an integer from 0 to 4.
  • R 1 represents a hydrogen atom or a methyl group
  • R 2 represents a hydrogen atom or a carbon atom
  • N represents an alkyl group of 1 to 6
  • n represents an integer of 0 to 20
  • B represents an alkyl group having 16 carbon atoms, an alkoxy group having 16 carbon atoms, or a halogen atom
  • L represents an integer from 0 to 5
  • B represents an integer from 0 to 4.
  • the cationically curable ultraviolet-curable composition of the present invention has very little yellowing after curing, so that it can improve the transparency of display materials such as liquid crystal displays, plasma displays and touch panels, and optical lenses. It can be suitably used as a required optical material.
  • the compound represented by the formula (4) can be suitably used as a raw material of a cured product requiring transparency.
  • FIG. 1 Slide glass and polyethylene terephthalate used in Examples and Comparative Examples
  • FIG. 3 shows an ultraviolet-visible absorption spectrum of a (PET) film.
  • FIG. 2 shows an ultraviolet-visible absorption spectrum in evaluation of transparency of a cured product (part 1).
  • FIG. 3 shows an ultraviolet-visible absorption spectrum in evaluation of transparency of a cured product (part 2).
  • FIG. 4 shows an ultraviolet-visible absorption spectrum in evaluation of transparency of a cured product (part 2).
  • the horizontal axis of FIG. 14 is wavelength (nm), and the vertical axis of FIG. 14 is transmittance (%).
  • Thick and solid line in FIG. 2 transmittance of the composition of Example 3 sandwiched between glass slides and cured.
  • Thick solid line in Fig. 3 transmittance of the composition of Example 3 cured on PMMA Thin solid line in Fig. 3: Transmittance of the composition of Comparative Example 2 cured on PMMA Fig. 3 Dashed line: Transmittance of the composition of Comparative Example 3 cured on PMMA Thick solid line in Fig. 4 Transmittance of the composition obtained by curing the composition of Example 3 on PMMA Thin and solid line in FIG. 4: Transmittance of the composition obtained by curing the composition of Comparative Example 4 on PMMA Dashed line in FIG. 4: Composition of Comparative Example 5 Of PMMA cured on PMMA Best mode for carrying out the invention
  • the ultraviolet-curable composition of the present invention comprises at least one compound represented by the following formula (1),
  • the ultraviolet-curable composition of the present invention forms a cationically polymerizable resin.
  • R 1 represents a hydrogen atom or a methyl group
  • n represents an integer of 0 to 20
  • B represents an alkyl group having 1 to 6 carbon atoms, an alkoxy group having 1 to 6 carbon atoms, Or, represents a halogen atom
  • the number L of substituents of B represents an integer from 0 to 5
  • the number m of substituents of B represents an integer from 0 to 4
  • Z represents the following formula (2) or the following formula ( Represents 3).
  • R 2 represents a hydrogen atom or an alkyl group having 116 carbon atoms.
  • R 3 represents a hydrogen atom or a methyl group.
  • the compound of the present invention is represented by the following formula (4), and the compound represented by the formula (4) can be suitably used for cation polymerization.
  • R 1 represents a hydrogen atom or a methyl group
  • R 2 represents a hydrogen atom or an alkyl group having 116 carbon atoms
  • n represents an integer of 0-20.
  • B represents an alkyl group having 16 carbon atoms, an alkoxy group having 16 carbon atoms, or a halogen atom
  • the number of substituents L of B represents an integer from 0 to 5
  • the number m of substituents m of B is Represents an integer from 0 to 4.
  • the compound represented by the formula (4) is a compound represented by the formula (1), wherein Z of the compound is the formula (2). Therefore, description of the compound represented by the formula (4) is omitted.
  • N in the formula (1) represents an integer of 0 to 20, preferably 0 to 5, and particularly preferably 0.
  • n 20 or less, the effect of reducing the yellowing of the cured product with a high concentration of the biphenyl skeleton is high, which is preferable.
  • B represents a monovalent substituent at any position on the aromatic ring
  • the number of substituents L represents an integer from 0 to 5
  • the number of substituents m of B represents an integer from 0 to 4.
  • B preferably represents an alkyl group having 16 carbon atoms, an alkoxy group having 16 carbon atoms, or a halogen atom, and is not limited to other groups as long as the cationic polymerization of the compound represented by the formula (1) is not inhibited. Any monovalent substituent can be selected.
  • the alkyl group and the alkoxy group may have a branch.
  • examples of the halogen atom include a fluorine atom, a chlorine atom, a bromine atom and an iodine atom.
  • a methyl group, a methoxy group, a methyl group which is preferably a fluorine atom or a bromine atom is particularly preferable.
  • L B and m B can be independently selected from the same or different substituents.
  • L and m in the formula (1) are preferably 0 or 2.
  • L and m in the formula (1) are 2, those bonded to the 3, 5, 3, 5, and 5 positions are preferred.
  • Z of the compound represented by the formula (1) is preferably a force Z represented by the formula (2) or (3), and preferably has an oxetane ring represented by the formula (2).
  • the bonding position of the compound having an oxetal group or an epoxy group in the above formula (1) of the present invention is at the 2-, 3- or 4-position, preferably at the 2- or 4-position.
  • the compound represented by the formula (1) is obtained by converting the compound represented by the formula (5) and the oxetane compound represented by the formula (6) or the epoxy conjugate represented by the formula (8) to an alkali. It can be obtained by reacting in the presence. A solvent may be used if necessary in this reaction. Further, a phase transfer catalyst may be used. [0048]
  • R 1 represents a hydrogen atom or a methyl group
  • n represents an integer of 0 to 20
  • B represents an alkyl group having 1 to 6 carbon atoms
  • B represents an alkyl group having 1 to 16 carbon atoms.
  • the number of substituents L of B represents an integer from 0 to 5
  • the number of substituents m of B represents an integer from 0 to 4.
  • R 2 represents a hydrogen atom or an alkyl group having 116 carbon atoms.
  • R 3 represents a hydrogen atom or a methyl group.
  • those other than ⁇ -force O are 2-phenylphenol, 3-phenylphenol or 4-phenylphenol, and their nucleus-substituted products are ethylene oxide or propylene oxide.
  • Compound represented by the formula (5) The number of n in the compound represented by the formula (1) is controlled by controlling the amount of ethylene oxide or propylene oxide to be added. can do.
  • the substituent B can be introduced into the nucleus of the raw material phenol by a known method, for example, a methyl group can be introduced by a Friedel-Crafts reaction.
  • n is an integer, but when it is a mixture of different numbers of n, n may be represented by a number having a decimal point. is there . In this case, n represents the average value of a mixture of compounds represented by the formula (1) having different numbers of n.
  • Examples of the oxetane compound represented by the formula (6) used in the present invention include 3-alkyl 3-chloromethyloxetane and 3-chloromethyloxetane.
  • Examples of the 3-alkyl 3-chloromethyloxetane include 3-chloromethyl-3-methyloxetane, 3-chloromethyl-3-ethyloxetane, and 3-chloromethyl-3-propyloxetane.
  • 3-alkyl-3-chloromethyloxetane is preferred, and 3-chloromethyl-3-methyloxetane or 3-chloromethyl-3-ethyloxetane is more preferred.
  • the compound represented by the formula (5) and the compound represented by the formula (6) or (8) are also used when synthesizing the compound represented by the formula (1).
  • the alkali include an alkali metal, an alkali metal hydroxide, an alkali metal carbonate, an alkaline earth metal hydroxide, an alkaline earth metal carbonate, and an alkali metal hydride.
  • Metal, alkali metal hydroxide or alkali metal hydride A plurality of these alkalis may be used in combination.
  • Specific examples of alkalis used in this synthesis include sodium hydroxide, potassium hydroxide, lithium hydroxide, calcium hydroxide, sodium carbonate, potassium carbonate, sodium hydride, potassium hydride, and sodium metal. , And metallic potassium.
  • sodium hydroxide and potassium hydroxide are preferred also because of the reason that a sufficient transfer ratio can be obtained in a short time.
  • the amount of the alkali to be used is preferably 1 mol or more, more preferably 18 mol, particularly preferably 1 mol, to 1 mol of the compound represented by the formula (5). It is. In consideration of the post-treatment, one mole of the alkali is added to one mole of the compound represented by the formula (5). Can be used. When used as an aqueous solution or suspension of an alkali, the alkali concentration is preferably from 1 to 96% by weight, more preferably from 20 to 96% by weight.
  • alkali metal hydroxide preferably, a 5-60% by weight aqueous solution or a powdered sodium hydroxide or potassium hydroxide is used, and more preferably, a 40-50% by weight aqueous solution. Is used.
  • a solvent inert to the raw materials and the reaction products can be used.
  • This solvent is preferably a solvent that azeotropes with water generated in the system during synthesis.
  • the solvent include benzene, toluene, xylene, ethylbenzene, methylcyclohexane, ethylcyclohexane, n-butynoleatel and the like.
  • the reaction time can be reduced by distilling the water generated in the synthesis system together with the solvent.
  • the amount of the solvent is preferably 0.05 to 100 parts by weight, more preferably 0.1 to 20 parts by weight, based on 1 part by weight of the total of the raw material and the reaction product in the reactor.
  • the amount of the solvent is within the above range, the yield per unit volume is high, the energy for recovering the solvent is small, and it is economical.
  • toluene, xylene, methylcyclohexane, ethylcyclohexane and the like are suitably used.
  • phase transfer catalyst that can be used in the synthesis of the compound represented by the formula (1)
  • known phase transfer catalysts for example, WP Weber, GW Gokel, Iwao Tabushi, Takako Nishitani, “ ! (Shift catalyst) and those described in “Chemical Doujin Co., Ltd.
  • organic quaternary ammonium salts and phosphonium salts are preferred because of their high catalytic ability.
  • Specific examples include tetra-n-butylammonium-bromobromide, benzyltriethylammonium-bromobromide, trioctylmethylammo-bromochloride, tetra-n-butylphospho-bromochloride, trioctylethylphospho-pambromide and tetraphenylphospho-bromochloride. And the like.
  • the reaction temperature at the time of synthesizing the compound represented by the formula (1) is preferably from 80 to 150 ° C, particularly preferably from 100 to 120 ° C.
  • the reaction time for synthesizing the compound represented by the formula (1) depends on the reaction temperature and whether or not a phase transfer catalyst is used, but is preferably 4 to 50 hours.
  • the reaction solution cooled to room temperature is washed with water, distilled, and the like, whereby the target compound (target substance) represented by the formula (1) can be obtained.
  • the desired product can be confirmed by J HN MR and 13 C-NMR spectrum.
  • Z is preferably represented by the formula (2) or from the curability of the power composition represented by the formula (2) or (3) or A compound represented by the formula (3), which is an R 3 methyl group, is more preferably a compound represented by the formula (2).
  • R 2 in the formula (2) represents a hydrogen atom or an alkyl group having 116 carbon atoms, and the alkyl group may have a branch.
  • R 2 is preferably a methyl group or an ethyl group.
  • composition of the present invention contains at least one compound represented by formula (1), and the kind of R ⁇ R 2, R 3 and substituents B, L, m, n number of It is possible to use a mixture of a plurality of compounds having different formulas, and it is also possible to use a mixture of compounds having different Z in the formula (1).
  • the bonding position is at the 2-position, the compound is liquid at room temperature, so that the composition is liquid even if the number of components is increased. Therefore, it is preferable that the compound having an oxetanyl group or an epoxy group be bonded at the 2-position.
  • the binding site of the compound having an oxetanyl group or an epoxy group is preferably at the 2-position.
  • the total compounding amount of the compound represented by the formula (1) is not particularly limited, but is preferably from 10 to 99, based on 100 parts by weight of the cationically polymerizable component. Parts by weight, more preferably 20 to 90 parts by weight, particularly preferably 30 to 80 parts by weight. When the blending number is within the above range, the effect of reducing yellowing of the cured product is high!
  • the cationically polymerizable components include a compound represented by the formula (1), a compound A having two or more cationically polymerizable groups, and a compound B having one cationically polymerizable group.
  • the cationic polymerizable group include an epoxy group, an oxetane group, and a vinyl ether group.
  • the compound represented by the formula (1) can be used for applications where the transparency of the cured product is not required. I'm sorry.
  • the cationic polymerization initiator in the present invention acts so as to generate an acid component by being activated by adaptation of light or heat to induce cationic polymerization of the cationically polymerizable group in the composition. is there.
  • the cationic polymerization initiator it is preferable to use any light-powered thione polymerization initiator that is activated by irradiation with light and can induce polymerization of the cationically polymerizable group. Further, a photosensitizer can be used in combination. Further, as the cationic polymerization initiator, any thermal cationic polymerization initiator can be used as long as it is activated by heating and can induce polymerization of the cationically polymerizable group.
  • the photo-thione polymerization initiator in the present invention is a compound that generates an acid capable of undergoing cationic polymerization by irradiation with ultraviolet light.
  • Examples of the photoinitiated thione polymerization initiator include oxalate salts and organometallic complexes.
  • organometallic complexes examples include an iron-allene complex, a titanocene complex, and an arylsilanol aluminum complex.
  • o-pium salts include diazo-pium salt, odonium salt, sulfo-pum salt, selenium salt, pyridi-p-m salt, ferrose-pum salt, phospho-pum salt, and Dipium salt and the like.
  • sulfode such as an aromatic sulfo-dum salt, dialkylphenacyl sulfo-dum salt or the like is preferred in terms of curability and less yellowing.
  • -Pham salts are preferred, aromatic sulfo-pam salts are more preferred, and triaryl sulfo-pam salts are particularly preferred.
  • the anion is BF-AsF-
  • triarylsulfo-pium salts include Cyracure UVI-6990, UVI-6992, and UVI-6974 manufactured by Dow Chemical Japan, and Asahi Denka Kogyo Co., Ltd. Adeki Optomatic SP-150, SP-152, SP-170, SP-172, etc., WP AG-593, WPAG-596, WPAG-640, WP AG-641, etc. manufactured by Wako Pure Chemical Industries, Ltd. And can be used in the present invention.
  • aromatic rhododium salts include UV-9380C manufactured by GE Toshiba Silicone, PHOTOINITIATOR2074 manufactured by Rhodia, WPI-116, WPI-113 and CD-1012 manufactured by Wako Pure Chemical Industries, Ltd. (trade names) And Sartoma Co., Ltd.).
  • UVI-6990 and UVI-6992 are particularly preferred in terms of curability and low yellowing.
  • the blending amount of the photo-induced thione polymerization initiator in the present invention can be appropriately adjusted according to the type and irradiation amount of ultraviolet rays.
  • the amount of the photoinitiated thione polymerization initiator be within the above range, since sufficient curability can be obtained, and heat resistance after polymerization and low water absorption are also sufficient.
  • a sensitizer may be used in combination with the composition of the present invention in order to increase the activity of the photoinitiated thione polymerization initiator.
  • the sensitizer that can be used in the present invention it is possible to use a compound disclosed by Krivero in Advanced in Polymer Science (Adv. In Plymer Sci., 62, 1 (1984)). Specific examples include pyrene, perylene, atalidine orange, thioxanthone, 2-cloth thioxanthone, and benzoflavin.
  • a compound widely used as a photo-radical polymerization initiator can also be used.
  • the radical polymerization initiator is used.
  • the radical polymerization initiator include compounds that generate a radical by heat, light, a redox reaction, or the like. Examples of such a substance include an organic peroxide, an azoi compound, a redox initiator, and the like.
  • benzoxanone such as benzophenone, 2,4 getylthioxanthone, 2 isopropylthioxanthone, 2,4 dichloromouth thioxanthone
  • benzoin ether such as benzoin methyl ether, benzoin ethyl ether, benzoin isopropyl ether
  • Benzyldimethyl ketals such as 2,2-dimethoxy-1,2-diphenyl-1-one, 2-hydroxy-2-methyl-1-phenylpropane-1 on, 1- (4-isopropylpropyl) -2-hydroxy-2- To methyl propane 1 on, 1-hydroxycyclo ⁇ -Hydroxyalkylphenones such as xylphenol ketone; ⁇ -dicarboxylic conjugates such as camphorquinone; and the like.
  • a sulfo-dimethyl salt is used as a photothione polymerization initiator and no sensitizer is used. Is preferred.
  • the wavelength range of ultraviolet light used for curing the composition is not particularly limited, but is preferably 200 to 380 nm in consideration of both curability and low yellowing. When importance is placed solely on the small amount of yellowing, it is preferably from 300 to 380 nm, particularly preferably from 320 to 380 nm.
  • the light source that can be used in the case of performing polymerization using an active energy ray is not particularly limited, but has a light emission distribution at a wavelength of 400 nm or less, such as a low-pressure mercury lamp, a medium-pressure mercury lamp, and a high-pressure mercury lamp.
  • a low-pressure mercury lamp such as a low-pressure mercury lamp, a medium-pressure mercury lamp, and a high-pressure mercury lamp.
  • Mercury lamps, ultra-high pressure mercury lamps, chemical lamps, black light lamps, microwave-excited mercury lamps, metal halide lamps, and the like can be used.
  • the light irradiation intensity of the composition is controlled for each target product and is not particularly limited.However, the light wavelength range effective for activating the cationic photoinitiator having photolatitude is used.
  • the light irradiation intensity (depending on the polymerization initiator) is 0.1-100 mW / cm 2 . It is preferable that the light irradiation intensity of the composition be within the above range, since the reaction time is appropriate. Further, it is preferable because the heat irradiated by the lamp power and the heat generated during the polymerization of the composition do not cause a decrease in cohesive strength, yellowing or deterioration of the support of the obtained cured product.
  • the light irradiation time for the composition is controlled for each target product and is not particularly limited, and is expressed as a product of the light irradiation intensity and the light irradiation time in the light wavelength region.
  • the integrated light amount is set to be 10-5, OOOmi / cm 2 .
  • the integrated light amount of the composition is within the above range, the generation of the active species from the initiator is sufficient, and the characteristics of the obtained cured product are not deteriorated. Further, the irradiation time is short, which is preferable since productivity is improved.
  • most of the compositions are dried to the touch by cationic polymerization 0.1 to several minutes after the irradiation with the active energy ray, but it is sometimes preferable to use heating in combination to promote the cationic polymerization reaction. Better.
  • the compound A having two or more cationically polymerizable groups to be blended in the composition of the present invention preferably has 10 or less, more preferably 5 or less, thiothionizable groups.
  • Examples of the compound A having two or more cationically polymerizable groups include a compound A having an epoxy group, a compound A having an oxetanol group, and a compound A having a vinyl ether group. Mixtures can be used.
  • a bifunctional glycidyl ether-type epoxy compound is preferred when adhesion is important, and a difunctional or higher functional epoxy compound is preferred when curability is preferred.
  • Preferred are cyclic epoxy conjugates and Z or oxetane compounds. When the elastic modulus at or above the glass transition temperature is to be improved, trifunctional or higher is preferred.
  • the compound A is preferably contained in an amount of 1 to 80 parts by weight, more preferably 5 to 60 parts by weight, based on 100 parts by weight of the compound component containing a cationically polymerizable group of the composition of the present invention. More preferably, it is contained in an amount of 10 to 50 parts by weight.
  • Examples of the compound A having an epoxy group include dicyclopentagendioxide, limonene dioxide, 4-butylcyclohexenedioxide, 3,4 epoxycyclohexylmethylenoleate 3,4-epoxycyclohexanyl ureboxylate, (3,4-epoxycyclohexyl) adipate, bisphenol A epoxy resin (bisphenol A diglycidyl ether), halogenated bisphenol A epoxy resin, hydrogenated bisphenol A epoxy resin , Bisphenol S diglycidyl ether, halogenated bisphenol S diglycidyl ether, hydrogenated phenol bisphenol S diglycidyl ether, bisphenol F type epoxy resin, halogenated bisphenol F type epoxy resin, hydrogenated bisphenol F-type epoxy resin, 1, 6 Hexanediol diglycidyl ether, polytetramethylenglycol diglycidyl ether, compounds in which both ends of polybutadiene are glycidyl etherified,
  • Epoxy novolak resin trimethylolpropane triglycidyl ether, pentaerythritol tetraglycidyl ether, 3,4-epoxycyclohexylmethyl-3 ', 4' epoxycyclohexanecarboxylate, 2- (3,4-epoxycyclo) Xinole 5,5-spiro 3,4-epoxy) cyclohexane metadioxane, bis (3,4-epoxycyclohexylmethyl) adipate, bis (3,4-epoxy 6— Methylcyclohexylmethyl) adipate, 3,4 epoxy 6-methylcyclohexyl 3 ', 4' epoxy 6'-methylcyclohexanecarboxylate, methylenebis (3,4 epoxycyclohexane), dicyclopentadiene epoxide, ethylene Glycol di (3,4-epoxycyclohexylmethyl) ether, ethylenebis
  • JP-A-8-85775 and JP-A-8-134405 various kinds of oxetane conjugates described in JP-A-8-85775 and JP-A-8-134405 are exemplified, and among them, a compound having two or more oxetal groups can be used. it can.
  • Examples of the compound A having a butyl ether group include cyclohexane dimethanol dibutyl ether, triethylene glycol divinyl ether, and novolak type divinyl ether.
  • Examples of the compound B to be added to the composition of the present invention include a compound B having an epoxy group, a compound B having an oxetal group, and a compound B having a vinyl ether group. It can also be used.
  • Compound B is preferably contained in an amount of 5 to 60 parts by weight, more preferably 10 to 50 parts by weight, based on 100 parts by weight of the compound component containing a cationically polymerizable group of the composition of the present invention. Is more preferable! / ,.
  • Examples of the compound B having an epoxy group include ⁇ -methyl phenylepoxide, phenylglycidyl ether, and 2-ethylhexyl, such as butylcyclohexene oxide, 4-butylepoxycyclohexane, and 1,2-epoxyhexadecane.
  • Glycidyl ether dodecyl glycidyl ether, glycidyl methacrylate, dioctyl epoxyhexahydrophthalate, di-2-ethylhexyl epoxyhexahydrophthalate, monoglycidyl ethers of higher aliphatic alcohols; phenol, cresol, butylphenol Or monoglycidyl ethers of polyether alcohols obtained by adding alkylene oxide thereto; monoglycidyl esters of higher fatty acids;
  • Examples of the compound having a butyl ether group include hydroxyethyl butyl ether, hydroxybutynolebininoleatene, dodecinolebininoleatene, propeninoleatenolepropylene carbonate and cyclohexylvinyl And the like.
  • compounds having an oxetanyl group are excellent in curability, and thus can be preferably added to the composition of the present invention.
  • a monofunctional compound having an oxetanyl group that is, a compound having one oxetal group in one molecule
  • the cured product of the present invention can be applied to a substrate having difficult adhesion.
  • a particularly preferable example is 3-ethyl-3- (phenoxymethyl) oxetane (aronoxetane II- 211 (II)).
  • a compound having at least one radically polymerizable group in the molecule may be blended as a polysynthetic component.
  • acrylates (meth) acrylic acid, (meth) acrylamide, N-methylol (meth) acrylamide, N-methoxymethyl (meth) acrylamide and N-methoxybutyl (meth) acrylamide.
  • the (meth) atalyloyl group means an atalyloyl group and a methacryloyl group.
  • compounds having one (meth) atalyloyl group include, for example, N-butylpyrrolidone, tetrahydrofurfuryl (meth) atalylate, and 2-ethylhexyl acrylate Hydroxyalkyl (meth) acrylates, such as 2-hydroxyethyl (meth) acrylate and 2-hydroxypropyl (meth) acrylate, and alkylene oxides of phenol, such as phenol and ethylene oxide (Meta) acrylates of adducts, (meta) acrylates of alkyl phenols such as noyulphenol, alkylene oxides such as ketene, etc.
  • the above-mentioned alkyl is a lower alkyl group which may have a branch, and specifically, has 16 to 16 carbon atoms such as ethyl and propyl.
  • the above-mentioned alkylene is a lower alkyl group which may have a branch, and specifically, an alkylene having a carbon number of 116 such as ethylene and propylene.
  • the above-mentioned alkylene oxides are those composed of good lower alkylenes such as ethylene and propylene. In the cationically curable composition of the present invention, two or more of these compounds are used in combination.
  • a compound having two or more atariloyl groups in one molecule includes a diatalylate of ethylene oxide-modified bisphenol F (for example, "Aronix M208 manufactured by Toagosei Co., Ltd.) )), Diatalylate of ethylene oxide-modified bisphenol A (for example, “Aronix M210" manufactured by Toagosei Co., Ltd.), and diatalylate of propylene oxide-modified bisphenol A (for example, "Light Atarilate BP” manufactured by Kyoeisha-Danigaku Co., Ltd.) — 4PA ”), ethylene oxide-modified isocyanuric acid diatalylate (eg, Seiko Co., Ltd.
  • ethylene oxide-modified isocyanuric acid diatalylate eg, Seiko Co., Ltd.
  • Alonics M215 polypropylene glycol diatalylate
  • Polypropylene glycol diatalylate eg, Toagosei Co., Ltd.
  • Alonics M225 polyethylene glycol diatalylate
  • Polyethylene glycol diatalylate eg, Toagosei Co., Ltd.
  • “Aronics M240”) Polytetramethylene glycol diatalylate (for example, “Kyoeisha-Danigaku Co., Ltd.“ Light Atarilate PTMGA-250 ”), pentaerythritol di-atalylate monostearate (eg, Toagosei Co., Ltd.“ Aronix M233 ”), Neopentyldaricole diatalylate, hexanediol diatalylate, nonanediol diatalylate, dimethylol tricyclodecane diatalylate (for example, “Kyoeisha Chemical Co., Ltd.“ Light Atalylate DCP-A ”), trimethylolpropane Acrylic acid benzoate (for example, Kyoeisha Co., Ltd.
  • Light Atarilate BA-134" hydroxypivalic acid neopentyl cholesteric alcohol diatalylate (for example, Kyoeisha I-Danigaku Co., Ltd. "Light Atarilate HPP-A"), pentaerythritol triatalylate ( For example, “Aronix M305” manufactured by Toagosei Co., Ltd., trimethylolpropane triatalylate (eg, “Aronix M309” manufactured by Toagosei Co., Ltd.), and alkylene oxide-modified trimethylolpropanetriatalylate (eg, manufactured by Toagosei Co., Ltd.) "Alonics M310", “Alonics M350”), ethylene oxide-modified isocyanuric acid triatalylate (eg, Toagosei Co., Ltd.
  • composition of the present invention may optionally contain a filler such as silica, alumina, and other metal oxides. Thereby, thixotropy can be imparted.
  • a material having ion exchangeability When used as an electrical insulating material or when a corrosive substrate is used, it is preferable to add a material having ion exchangeability, more preferably an inorganic material, and particularly preferably a negative electrode. It has ion exchange ability.
  • suitable inorganic anion exchangers include IXE-500, IXE-530, IXE-550, IXE-700, and IXE-800 (V, the deviation is also manufactured by Toagosei).
  • a coupling agent such as a silane coupling agent can be added to the composition of the present invention for the purpose of improving the adhesion of the cured product to an inorganic material.
  • Suitable silane coupling agents include ⁇ - (3,4 epoxycyclohexyl) ethyltrimethoxysilane (Shin-Etsu Chemical Co., Ltd., ⁇ -303), and ⁇ -glycidoxypropyltrimethoxysilane (Shin-Etsu Rigaku Co., Ltd.) , ⁇ -403), ⁇ -glycidoxypropyltriethoxysilane (Shin-Etsu Chemical Co., Ltd., ⁇ -403), ⁇ -glycidoxypropylmethyljetoxysilane (Shin-Etsu Iridaku, ⁇ -402), 3-ethylethyl 3 -— [[3- (triethoxysilyl) propoxy] methyl ⁇ oxetane
  • An antioxidant can be added to the composition of the present invention for the purpose of improving heat resistance and the like.
  • examples of the antioxidant to be contained in the composition of the present invention include a phenolic antioxidant, a zeolite antioxidant, a phosphorus antioxidant, and an amine antioxidant, and particularly preferred are It is a phenol-based antioxidant.
  • phenolic antioxidants examples include hydroquinone monomethyl ether, 2,6-di-t-butylhydroxytoluene (for example, BHT manufactured by Kawaguchi Chemical), 2,2-methylenebis (4-methyl-6-t-butylphenol), 4, 4'butylidenebis- (3-methyl-6-t-butylphenol), triethylene glycol bis- [3- (3,1-tert-butyl-4-hydroxy-5-methylphenol)] propionate, pentaerythritol-tetrakis [3 — (3,5-di-tert-butyl-4 —hydroxyphenyl) propionate] (Tinoku's Irgano manufactured by Specialty Chemicals) x 1010), n-octadecyl-3-([3,5, di-tert-butyl-4, -hydroxyphenyl) propionate], 4,4, -thiobis (3-methyl-6-tert-butyl) phenol, etc.
  • a powdery reinforcing agent or filler such as metal oxides such as aluminum oxide and magnesium oxide may be used, if necessary.
  • metal carbonates such as calcium carbonate and magnesium carbonate, diatomaceous earth powder, basic magnesium silicate, calcined clay, fine powdered silica, fused silica, crystalline silica and other metal compounds, and metal water such as aluminum hydroxide Oxides, other materials, such as kaolin, myriki, quartz powder, graphite, molybdenum disulfide, and other fibrous reinforcing agents and fillers such as glass fiber, ceramic fiber, carbon fiber, alumina fiber, and silicon carbide fiber , Boron fiber, polyester fiber, polyamide fiber and the like. These can be added in an amount of 10 to 900 parts by weight based on 100 parts by weight of the composition of the present invention.
  • a coloring agent for example, titanium dioxide, iron black, molybdenum red, dark blue, ultramarine, cadmium yellow, cadmium red, antimony trioxide, red phosphorus, and a bromide compound And triphenyl phosphate and the like.
  • a coloring agent for example, titanium dioxide, iron black, molybdenum red, dark blue, ultramarine, cadmium yellow, cadmium red, antimony trioxide, red phosphorus, and a bromide compound And triphenyl phosphate and the like.
  • various curable monomers, oligomers and synthetic resins can be added to the composition of the present invention for the purpose of improving the properties of the resin in the molded article and the like.
  • diluents for epoxy resin such as monoepoxy, phenol resin, alkyd resin, melamine resin, fluorine resin, chlorinated vinyl resin, acrylic resin, silicone resin, polyester resin, etc. Two or more combinations can be given.
  • the mixing ratio of these resins is within a range that does not impair the cationic polymerizability, which is the original property of the composition of the present invention, that is, 50 parts by weight or less for 100 parts by weight of the composition of the present invention. Is preferred.
  • composition of the present invention examples include heat-melt mixing, melt-kneading using a roll or a kneader, wet mixing using an appropriate organic solvent, and dry mixing.
  • the composition of the present invention is cured by heat when a thermal cationic polymerization initiator is used, or by an active energy ray when an active energy linear cationic polymerization initiator is used.
  • the thermal cationic polymerization initiator is usually carried out at a temperature not lower than the temperature at which the generation of cationic species or Lewis acid is started, usually at 50 to 200 ° C.
  • heat can be applied by a generally known method, and the conditions and the like are not particularly limited.
  • composition containing the formula (1) of the present invention can be cured by irradiation with a small amount of active energy rays (ultraviolet rays or the like) since oxygen inhibition during polymerization is small. The same applies to polymerization by heat.
  • active energy rays ultraviolet rays or the like
  • Examples of the method of using the composition of the present invention in which the formula (1) is blended include a method of applying the composition to a substrate and then irradiating the composition with ultraviolet light.
  • Examples of the substrate include molded resin products (plastics) such as polycarbonate and polymethylmethacrylate, metals, glass, concrete, wood such as natural wood and synthetic wood, stone materials, and paper.
  • the cationically curable ultraviolet-curable composition of the present invention has very little yellowing after curing, so that it can improve the transparency of display materials such as liquid crystal displays, plasma displays and touch panels, and optical lenses. It can be suitably used as a required optical material. That is, the cured product of the composition of the present invention can be suitably used for an optical material. Examples of use of the composition of the present invention are illustrated below. For example, it can be used for a lens sheet light guide plate of a liquid crystal display and its surface. It is also used as a diffusion sheet when used as a binder for liquid crystal displays, etc., as a hard coat on the surface of various films such as deflection films for liquid crystal displays, etc. It can be used as a liquid crystal sealant.
  • a material for covering the wiring of the plasma display touch panel as a material for bonding the edge of the display screen, as a dot spacer for the touch panel, as a DVD substrate, as a DVD substrate, Used as an adhesive for DVDs, as a coating layer for DVDs, as a core / clad for optical waveguides, as a lens for various optical devices, as a sealing part for blue LEDs, and as a sealing part for white LEDs can do.
  • the cured product of the composition of the present invention has a high refractive index, and is excellent in curability, heat resistance, flame retardancy, and mechanical properties. Therefore, it can be used for paints and coating materials, adhesives and the like. [0102] ⁇ Example>
  • reaction solution was stirred for 14 hours while maintaining the temperature at about 110 ° C. Thereafter, 0.3 mol of 3-chloromethyl-3-ethyloxetane and 0.02 mol of tetrabutylammonium-bromobromide were added to the reaction solution, and the reaction solution was stirred for further 3 hours while maintaining the reaction solution at about 110 ° C.
  • reaction solution was cooled to room temperature, 250 g of water and 250 g of toluene were dried and extracted, and separated into an organic layer and an aqueous layer. The obtained organic layer was washed three times with 250 g of water. The solvent was distilled off from the obtained organic layer under reduced pressure to obtain 255 g of a crude product.
  • the crude product was purified by distillation under reduced pressure (192 ° C-196 ° C, 400 Pa), and 4 [(3-ethyloxetane-3-yl) methoxy] biphenyl (formula (10) below) was converted to a white solid. 223. lg (yield: 83%, purity: 99%) was obtained.
  • Table 1 After mixing the components and their proportions shown in Table 1 according to a conventional method to prepare a cationically curable ultraviolet-curable composition, various physical properties were evaluated.
  • the abbreviations in Table 1 indicate the following compounds.
  • the values in Table 1 are parts by weight.
  • YD128 Bisphenol A type epoxy resin (Toto Kasei Co., Ltd.)
  • OPP-G orthophenylphenol glycidyl ether (Sanko Co., Ltd.)
  • UVR6110 3,4 Epoxycyclohexylmethyl-3,4 Epoxycyclohexane power 2-BPMOX: Compound synthesized above
  • RSOX Compound represented by the following formula (12) (developed by Toagosei Co., Ltd.)
  • HQOX a compound represented by the following formula (13) (developed by Toagosei Co., Ltd.)
  • TMPOX Compound represented by the following formula (14) (Developed by Toagosei Co., Ltd.)
  • A200 Athalylate having alicyclic epoxy group (Cyclomer A200, manufactured by Daicel Chemical Industries, Ltd.)
  • UVI-6992 Triaryl sulfo-dimethylhexafluorophosphate (Dow Chemical Nippon Co., Ltd., photo-induced thione polymerization initiator)
  • Example 3 Transparency was evaluated for each of the compositions of Example 7 and Comparative Example 1 which were cured by irradiation with ultraviolet rays. That is, a double-sided tape was attached to one side of a 1-mm-thick slide glass to form a spacer, and the composition was placed between the two pieces of glass.
  • the UV irradiation conditions were a 60 WZcm high-pressure mercury lamp, a lamp height of 30 cm (150 mWZcm 2 ), an irradiation time of 20 seconds, and irradiation from only one side.
  • the UV-visible absorption spectrum of the used slide glass is shown in Fig. 1 for reference.
  • the thickness of the cured resin portion was about 0.25 mm.
  • the visible absorption spectrum of the cured product was measured without sandwiching a substrate or the like on the reference light side in a state of being sandwiched between two slide glasses.
  • the measurement results are shown in Figure 2 (transmittance spectrum from 380 to 700 nm) and Table 3 (transmittance at 400 nm and 380 nm).
  • the transmittance around 400 nm is clearly higher and the yellowing is smaller than that of the comparative example 1.
  • Example 3 and Comparative Example 2 Transparency was evaluated for each of the compositions of Comparative Example 5 which were cured by irradiation with ultraviolet rays. That is, a lmm-thick PMMA substrate is enclosed on one side with double-sided tape to form a spacer, the composition is placed in it, and a 50 ⁇ m-thick layer from the top is used to smooth the cured surface.
  • a PET film (Lumirror 50-T60, manufactured by Toray Industries, Inc.) was laminated, irradiated with ultraviolet light, and cured.
  • the UV irradiation conditions were a 60 WZcm high-pressure mercury lamp, a lamp height of 30 cm (150 mWZcm 2 ), and an irradiation time of 30 seconds.
  • Irradiation was performed only from the PET side.
  • the UV-visible absorption spectrum of the PET film used is shown in FIG. Then, in order to see yellowing when directly irradiating light with a light source power, Removed and irradiated for 15 seconds.
  • the thickness of the resin portion after curing was about 0.25 mm.
  • Example 3 Each of the compositions of Example 5, Comparative Example 2 and Comparative Example 3 was evaluated for curability and adhesion.
  • Example 3 Comparing the refractive indices of Example 3 and Comparative Example 3, Example 3 is higher. This indicates that it is better to use a compound having one oxetanyl group than a compound having two oxetanyl groups. Further, as shown in Examples 3 and 4, it is shown that a coating film having good adhesion and transparency can be obtained and the refractive index can be controlled.
  • the cationically curable ultraviolet-curable composition of the present invention has very little yellowing after curing, so that it can improve the transparency of display materials such as liquid crystal displays, plasma displays, touch panels, and optical lenses. It can be suitably used as a required optical material.
  • the cured product obtained from the composition containing the compound represented by the formula (4) of the present invention has a high refractive index, and is excellent in curability, heat resistance, flame retardancy, and mechanical properties. It can be used for paints, coating materials, adhesives and the like.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Polyethers (AREA)
  • Polymerisation Methods In General (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)

Abstract

Disclosed is a resin hardly suffering from yellowing and thus applicable to optical uses where colorlessness and transparency are strictly demanded. Also disclosed are a cationically curable ultraviolet-curing composition enabling to obtain such a resin and a method for producing the same. The ultraviolet-curing composition is characterized by containing at least one compound represented by the formula (1) below, a compound A having two or more cationically polymerizable groups and a cationic photopolymerization initiator. (1) In the formula (1), R1 represents a hydrogen atom or a methyl group; n represents an integer of 0-20; B represents an alkyl group having 1-6 carbon atoms, an alkoxy group having 1-6 carbon atoms or a halogen atom; L that is the number of substituents of B represents an integer of 0-5; m that is the number of substituents of B represents an integer of 0-4; and Z represents the formula (2) or the formula (3) below. (2) In the formula (2), R2 represents a hydrogen atom or an alkyl group having 1-6 carbon atoms. (3) In the formula (3), R3 represents a hydrogen atom or a methyl group.

Description

明 細 書  Specification
紫外線硬化型組成物  UV curable composition
技術分野  Technical field
[0001] 本発明は、液晶ディスプレイ、プラズマディスプレイ、およびタツチパネル等のディス プレイ、並びに光学レンズ等の透明性を必要とする光学材料として好適なカチオン 硬化性の紫外線硬化型組成物に関する。  The present invention relates to a cation-curable ultraviolet-curable composition suitable as a display such as a liquid crystal display, a plasma display, and a touch panel, and an optical material such as an optical lens that requires transparency.
さらに、本発明は、カチオン重合が可能なォキセタン環を有する新規なビフヱニル 誘導体およびその製造方法に関するものである。  Furthermore, the present invention relates to a novel biphenyl derivative having an oxetane ring capable of cationic polymerization and a method for producing the same.
背景技術  Background art
[0002] 紫外線硬化型組成物は、生産性に優れ、且つ微細な形状の硬化物を容易に付与 できる等の特長を有しているため、光学材料としても広く使用されている。例えば、液 晶ディスプレイ用のレンズシートは、微細な凹凸形状を有する金型に紫外線硬化型 組成物を流し込み、上カゝら透明のプラスチック基材を被せて紫外線照射して硬化さ せ、プラスチック基材を紫外線硬化型榭脂ごと離型させることで、金型の形状が転写 されたレンズシートを形成している。また、紫外線硬化型組成物は、拡散シートのバイ ンダーや各種フィルムの貼り合せ材料としても使用されて 、る。  [0002] An ultraviolet curable composition is widely used as an optical material because of its features such as excellent productivity and easy application of a cured product having a fine shape. For example, for a lens sheet for a liquid crystal display, a UV curable composition is poured into a mold having fine irregularities, covered with a transparent plastic substrate, cured by irradiating UV rays, and cured. By releasing the material together with the UV-curable resin, a lens sheet to which the shape of the mold has been transferred is formed. Further, the ultraviolet-curable composition is also used as a binder for a diffusion sheet or a material for bonding various films.
[0003] 紫外線硬化型組成物の原料の大部分は、アクリル系化合物であり、上述のような光 学用途においてもアクリル系化合物が大部分を占めている。しかし近年、紫外線硬 化型組成物を使用して、様々な構成の光学部材やその製法が考案されてきており、 それに応じて、紫外線硬化型組成物に対しても厳しい性能が求められている。この 例として、紫外線硬化型組成物にお!ヽて従来のアクリル系化合物では密着が困難な 基材に対し良好な密着性を有するもの、硬化時に低収縮なものおよび低吸水率なも の等が求められて 、る。そしてエポキシィ匕合物ゃォキセタンィ匕合物によるカチオン硬 化性の組成物は、これらの物性の点でアクリル系化合物に比べて良 、性能を有して いる。しかし、これらカチオン硬化性の紫外線硬化型組成物は、アクリル系化合物と 比べると硬化時の黄変を低減させることが困難である。このため、ディスプレイ等の透 明性が厳しく要求される光学用途にカチオン硬化性の紫外線硬化型組成物を適用 することが困難であった。 [0003] Most of the raw materials of the ultraviolet curable composition are acrylic compounds, and acrylic compounds occupy most of the optical applications as described above. However, in recent years, various types of optical members and methods for producing the same have been devised using ultraviolet-curable compositions, and accordingly, strict performance is required for ultraviolet-curable compositions. . For example, UV curable compositions! On the other hand, there are demands for a conventional acrylic compound having good adhesion to a substrate which is difficult to adhere to, a material having a low shrinkage upon curing, and a material having a low water absorption. The cationically curable composition using the epoxy conjugate compound and the oxetane conjugate compound has better and better performance in terms of these physical properties than the acrylic compound. However, these cationically curable ultraviolet-curable compositions are more difficult to reduce yellowing during curing than acrylic compounds. For this reason, cationically curable UV-curable compositions are used for optical applications such as displays that require strict transparency. It was difficult to do.
[0004] ォキセタンィ匕合物は、カチオン重合などによる硬化が可能なモノマーとして、近年 注目を浴びている化合物であり、多くのォキセタンィ匕合物が報告されている。例えば 、 3—アルキル 3—ヒドロキシメチルォキセタンと α , ω—ジブ口モアルカンとを水酸化 アルカリ金属水溶液および相間移動触媒の存在下に接触させて得られるビスォキセ タンエーテルィ匕合物が報告されている(例えば、例えば、非特許文献 1、非特許文献 [0004] Oxetane conjugates are compounds that have attracted attention in recent years as monomers that can be cured by cationic polymerization or the like, and many oxetane conjugates have been reported. For example, a bisoxetane ether conjugate obtained by contacting a 3-alkyl 3-hydroxymethyloxetane with an α, ω-dibumoalkane in the presence of an aqueous alkali metal hydroxide solution and a phase transfer catalyst has been reported. (For example, for example, Non-Patent Document 1, Non-Patent Document
2、非特許文献 3および特許文献 1参照。 ) 0また、 3 アルキル 3—ハロメチルォキセ タンと二価フエノール類のアルカリ金属フエノーラートとを接触させて得られるビスォキ セタンエーテルィ匕合物が報告されている (例えば、特許文献 2参照)。 See 2, Non-patent Document 3 and Patent Document 1. ) 0 The three alkyl 3 Haromechiruokise tongue and Bisuoki cetane ether I匕合obtained by contacting the alkali metal Fuenorato divalent phenols have been reported (e.g., see Patent Document 2).
[0005] また、様々なビスォキセタンエーテルィ匕合物が報告されて 、る(例えば、特許文献 3 、特許文献 4、特許文献 5、特許文献 6および特許文献 7等参照)。 [0005] Also, various bisoxetane ethereal conjugates have been reported (see, for example, Patent Document 3, Patent Document 4, Patent Document 5, Patent Document 6, Patent Document 7, etc.).
また、式 (a)で表されるォキセタンィ匕合物が報告されている(例えば、特許文献 8参 照)。  Also, an oxetanei conjugate represented by the formula (a) has been reported (for example, see Patent Document 8).
[0006] [化 1]  [0006] [Formula 1]
Figure imgf000004_0001
Figure imgf000004_0001
[0007] 式 (a)中、 R— Rは水素原子またはメチル基を示し、 Rおよび Rは水素原子また In the formula (a), R—R represents a hydrogen atom or a methyl group, and R and R represent a hydrogen atom or
1 4 5 6  1 4 5 6
は 1一 6個の炭素原子を有するアルキル基を示す。  Represents an alkyl group having 1 to 6 carbon atoms.
[0008] し力しながら、これらいずれの公知文献にも 1分子中に 1個のォセタン環を有するビ フエ-ル誘導体にっ 、ての記載がなぐまた示唆もな 、。  [0008] Although there has been no mention of biphenyl derivatives having one osetan ring in one molecule in any of these known documents, there is no suggestion or suggestion.
[0009] カチオン硬化性の組成物としては、エポキシィ匕合物および Zまたはォキセタンィ匕合 物であるカチオン重合性ィ匕合物、グリシジル基または 3—ェチルー 3—才キセタニルメ チル基をエーテル結合で有するフエ-レンおよびナフタレン等の芳香族エーテルィ匕 合物、並びに光力チオン開始剤を含有することを特徴とする光力チオン硬化性の組 成物が報告されている (例えば、特許文献 9参照)。 また、ビスフエノール型エポキシ (メタ)アタリレートおよび/またはウレタン (メタ)ァク リレート、ビニルエーテルィ匕合物、光力チオン重合開始剤並びに光ラジカル重合開 始剤を含むことを特徴とする透過型スクリーン用紫外線硬化型組成物が報告されて いる(例えば、特許文献 10参照)。また、エポキシ化合物中のエポキシ基の 5— 95% を (メタ)ァクロイルイ匕した重合性ィ匕合物および Zまたはフエノキシ榭脂中の水酸基の 5— 60%を a , β 不飽和モノイソシァネートと反応させて得られる重合性ィ匕合物と 光ラジカル重合開始剤および Ζまたは光力チオン重合開始剤とを含有するフレネル レンズ等に用いられる硬化性組成物が報告されて ヽる(例えば、特許文献 11参照)。 [0009] The cationically curable composition includes a cationically polymerizable conjugate, which is an epoxy conjugate or a Z or oxetane conjugate, a glycidyl group or a 3-ethyl-3,3-xentanylmethyl group having an ether bond. An aromatic etherified compound such as phenylene and naphthalene, and a photo-thione curable composition containing a photo-thione initiator have been reported (for example, see Patent Document 9). . In addition, a transmission type characterized by containing a bisphenol type epoxy (meth) acrylate and / or urethane (meth) acrylate, a vinyl ether conjugate, a photodynamic thione polymerization initiator and a photoradical polymerization initiator. An ultraviolet curable composition for a screen has been reported (for example, see Patent Document 10). Further, a polymerizable conjugate in which 5-95% of epoxy groups in the epoxy compound are (meth) acryloyl and 5-60% of hydroxyl groups in Z or phenoxy resin are a, β-unsaturated monoisocyanate. Curable compositions for use in Fresnel lenses and the like containing a polymerizable conjugate obtained by reacting with a polymerizable compound, a photoradical polymerization initiator, and a thione polymerization initiator. See Patent Document 11).
[0010] 特許文献 1 :特開平 6— 16804号公報 Patent Document 1: JP-A-6-16804
特許文献 2:ドイツ特許第 1021858号  Patent Document 2: German Patent No. 1021858
特許文献 3:特開平 7 - 53711号公報  Patent Document 3: JP-A-7-53711
特許文献 4 :特開平 7-173279号公報  Patent Document 4: JP-A-7-173279
特許文献 5:特開平 8— 245783号公報  Patent Document 5: JP-A-8-245783
特許文献 6:特開平 9— 309950号公報  Patent Document 6: JP-A-9-309950
特許文献 7:特開平 10- 212343号公報  Patent Document 7: JP-A-10-212343
特許文献 8 :特開 2001— 31665号公報  Patent Document 8: JP 2001-31665 A
特許文献 9:特開 2003-096184号公報  Patent Document 9: JP-A-2003-096184
特許文献 10:特開平 07— 199359号公報  Patent Document 10: JP-A-07-199359
特許文献 11 :特開 2001— 163939号公報  Patent Document 11: JP 2001-163939 A
非特許文献 l : Bull. Chem. Soc. Jpn. , 61 , pp. 1653 ( 1989)  Non-patent Document l: Bull.Chem.Soc.Jpn., 61, pp. 1653 (1989)
非特許文献 2 : Pure Appl. Chem. , A29 ( 10) , pp. 915 ( 1992)  Non-Patent Document 2: Pure Appl.Chem., A29 (10), pp. 915 (1992)
非特許文献 3 : Pure Appl. Chem. , A30 (2 & 3) , pp. 189 ( 1993)  Non-Patent Document 3: Pure Appl.Chem., A30 (2 & 3), pp. 189 (1993)
発明の開示  Disclosure of the invention
発明が解決しょうとする課題  Problems to be solved by the invention
[0011] 本発明が解決しょうとする課題は、無色透明性が厳しく要求される光学用途にも使 用可能な黄変が少ない榭脂を提供することであり、この榭脂を与えるカチオン硬化性 の紫外線硬化型組成物およびその製造方法を提供することである。 [0011] The problem to be solved by the present invention is to provide a resin having a small yellowing that can be used for optical applications where colorless and transparent properties are strictly required. And a method for producing the same.
さらに本発明の他の課題は、カチオン重合が可能であり、 1分子中に 1個のォキセ タン環を有する、新規なビフヱニル誘導体およびその製造方法を提供することである 。さらに、該新規なビフ -ル誘導体を含有する組成物およびその硬化物を提供す ることである。 Yet another object of the present invention is that cationic polymerization is possible, and that one An object of the present invention is to provide a novel biphenyl derivative having a tan ring and a method for producing the same. Another object of the present invention is to provide a composition containing the novel biphenyl derivative and a cured product thereof.
課題を解決するための手段  Means for solving the problem
[0012] 本発明者らは、前記課題を解決するために鋭意検討を重ねた結果、以下の手段( 1)により前記課題を解決し得ることを見出し、本発明を完成した。好ましい実施態様 である(2)— (7)と共に以下に記載する。  The present inventors have conducted intensive studies to solve the above problems, and as a result, have found that the above problems can be solved by the following means (1), and have completed the present invention. These are described below together with preferred embodiments (2) to (7).
(1)少なくとも一種の下記式(1)で表される化合物、 2個以上のカチオン重合性基を 有する化合物 Aおよび光力チオン重合開始剤を含むことを特徴とする紫外線硬化型 組成物、  (1) an ultraviolet-curable composition comprising at least one compound represented by the following formula (1), a compound A having two or more cationically polymerizable groups, and a photoactive thione polymerization initiator;
[0013] [化 2] [0013] [Formula 2]
Figure imgf000006_0001
Figure imgf000006_0001
[0014] (式(1)において、 R1は水素原子またはメチル基を表し、 nは 0— 20の整数を表し、 B は炭素数 1一 6のアルキル基、炭素数 1一 6のアルコキシ基、または、ハロゲン原子を 表し、 Bの置換基数 Lは 0— 5までの整数を表し、 Bの置換基数 mは 0— 4までの整数 を表し、また、 Zは下記式(2)または下記式(3)を表す。 ) (In the formula (1), R 1 represents a hydrogen atom or a methyl group, n represents an integer of 0 to 20, B represents an alkyl group having 1 to 16 carbon atoms, and an alkoxy group having 1 to 16 carbon atoms. Or a halogen atom, the number L of substituents of B represents an integer from 0 to 5, the number m of substituents of B represents an integer from 0 to 4, and Z represents the following formula (2) or the following formula: (Represents (3).)
[0015] [化 3]  [0015] [Formula 3]
Figure imgf000006_0002
Figure imgf000006_0002
[0016] (式(2)において、 R2は水素原子または炭素数 1一 6個のアルキル基を表す。 ) [0017] [化 4] (In the formula (2), R 2 represents a hydrogen atom or an alkyl group having 116 carbon atoms.) [0017] [Formula 4]
Figure imgf000007_0001
Figure imgf000007_0001
[0018] (式(3)にお 、て、 R3は水素原子またはメチル基を表す。 ) (In the formula (3), R 3 represents a hydrogen atom or a methyl group.)
[0019] (2) 1個のカチオン重合性基を有する化合物 Bを更に含む(1)に記載の紫外線硬化 型組成物、  (2) The ultraviolet-curable composition according to (1), further comprising a compound B having one cationically polymerizable group.
(3)光力チオン重合開始剤力 スルホ -ゥム塩である(1)または(2)に記載の紫外線 硬化型組成物、  (3) the ultraviolet curable composition according to (1) or (2), which is a sulfonate salt of a photoinitiated thione polymerization initiator;
(4) (1)または(2)に記載の組成物に紫外線を照射してなる硬化物、  (4) a cured product obtained by irradiating the composition according to (1) or (2) with ultraviolet light,
(5) (3)に記載の組成物に紫外線を照射してなる硬化物、  (5) a cured product obtained by irradiating the composition according to (3) with ultraviolet light,
(6)硬化物が光学材料である(4)に記載の硬化物、  (6) the cured product according to (4), wherein the cured product is an optical material,
(7)硬化物が光学材料である(5)に記載の硬化物、である。  (7) The cured product according to (5), wherein the cured product is an optical material.
[0020] さらに、以下の手段(8)および(10)により前記課題を解決し得ることを見出した。好 ましい実施態様である(9)と共に以下に記載する。  [0020] Further, it has been found that the above problem can be solved by the following means (8) and (10). It is described below together with the preferred embodiment (9).
(8)下記式 (4)で表される化合物、  (8) a compound represented by the following formula (4),
[0021] [化 5] [0021] [Formula 5]
Figure imgf000007_0002
Figure imgf000007_0002
(式 (4)において、 R1は水素原子またはメチル基を表し、 R2は水素原子または炭素数 1一 6個のアルキル基を表し、 nは 0— 20の整数を表し、 Bは炭素数 1一 6のアルキル 基、炭素数 1一 6のアルコキシ基、または、ハロゲン原子を表し、 Bの置換基数 Lは 0 一 5までの整数を表し、 Bの置換基数 mは 0— 4までの整数を表す。) [0023] (9) (8)に記載の式 (4)で表される化合物およびカチオン重合開始剤を含有する力 チオン硬化性組成物、 (In the formula (4), R 1 represents a hydrogen atom or a methyl group, R 2 represents a hydrogen atom or an alkyl group having 1 to 16 carbon atoms, n represents an integer of 0 to 20, and B represents a carbon number. It represents an alkyl group of 1 to 6, an alkoxy group of 1 to 6 carbon atoms, or a halogen atom, the number of substituents of B represents an integer of 0 to 5, the number of substituents of B is an integer of 0 to 4. Represents.) (9) A force-thione curable composition containing a compound represented by the formula (4) according to (8) and a cationic polymerization initiator,
(10)アルカリの存在下、式(5)で表される化合物と式 (6)で表わされる化合物とを反 応させることを特徴とする式 (7)で表される化合物の製造法、である。  (10) A method for producing a compound represented by the formula (7), which comprises reacting a compound represented by the formula (5) with a compound represented by the formula (6) in the presence of an alkali. is there.
[0024] [化 6] [0024] [Formula 6]
Figure imgf000008_0001
Figure imgf000008_0001
[0025] 式(5)にお!/、て、 R1は水素原子またはメチル基を表し、 nは 0— 20の整数を表し、 B は炭素数 1一 6のアルキル基、炭素数 1一 6のアルコキシ基、または、ハロゲン原子を 表し、 Bの置換基数 Lは 0— 5までの整数を表し、 Bの置換基数 mは 0— 4までの整数 を表す。 In the formula (5), R 1 represents a hydrogen atom or a methyl group, n represents an integer of 0 to 20, B represents an alkyl group having 16 carbon atoms, and B represents an alkyl group having 11 carbon atoms. 6 represents an alkoxy group or a halogen atom, the number of substituents L of B represents an integer from 0 to 5, and the number of substituents m of B represents an integer from 0 to 4.
[0026] [化 7]  [0026] [Formula 7]
Figure imgf000008_0002
Figure imgf000008_0002
[0029] 式(7)にお 、て、 R1は水素原子またはメチル基を表し、 R2は水素原子または炭素 数 1一 6個のアルキル基を表し、 nは 0— 20の整数を表し、 Bは炭素数 1一 6のアルキ ル基、炭素数 1一 6のアルコキシ基、または、ハロゲン原子を表し、 Bの置換基数 Lは 0— 5までの整数を表し、 Bの置換基数 mは 0— 4までの整数を表す。 In the formula (7), R 1 represents a hydrogen atom or a methyl group, and R 2 represents a hydrogen atom or a carbon atom. N represents an alkyl group of 1 to 6, n represents an integer of 0 to 20, B represents an alkyl group having 16 carbon atoms, an alkoxy group having 16 carbon atoms, or a halogen atom; L represents an integer from 0 to 5, and B represents an integer from 0 to 4.
発明の効果  The invention's effect
[0030] 本発明のカチオン硬化性の紫外線硬化型組成物は、硬化後の黄変が非常に少な いため、液晶ディスプレイ、プラズマディスプレイ、タツチパネル等のディスプレイ用材 料や、光学レンズ等の、透明性を必要とする光学材料として好適に使用する事がで きる。式 (4)で表される化合物は、透明性が必要とされる硬化物の原料として好適に 使用することができる。  [0030] The cationically curable ultraviolet-curable composition of the present invention has very little yellowing after curing, so that it can improve the transparency of display materials such as liquid crystal displays, plasma displays and touch panels, and optical lenses. It can be suitably used as a required optical material. The compound represented by the formula (4) can be suitably used as a raw material of a cured product requiring transparency.
図面の簡単な説明  Brief Description of Drawings
[0031] [図 1]実施例および比較例で使用したスライドガラスおよびポリエチレンテレフタレート  [FIG. 1] Slide glass and polyethylene terephthalate used in Examples and Comparative Examples
(PET)フィルムの紫外可視吸収スペクトルを示す。  3 shows an ultraviolet-visible absorption spectrum of a (PET) film.
[図 2]硬化物の透明性の評価 (その 1)における紫外可視吸収スペクトルを示す。  FIG. 2 shows an ultraviolet-visible absorption spectrum in evaluation of transparency of a cured product (part 1).
[図 3]硬化物の透明性の評価 (その 2)における紫外可視吸収スペクトルを示す。  FIG. 3 shows an ultraviolet-visible absorption spectrum in evaluation of transparency of a cured product (part 2).
[図 4]硬化物の透明性の評価 (その 2)における紫外可視吸収スペクトルを示す。 符号の説明  FIG. 4 shows an ultraviolet-visible absorption spectrum in evaluation of transparency of a cured product (part 2). Explanation of symbols
[0032] 図 1一 4の横軸:波長 (nm)、図 1一 4の縦軸:透過率(%)  The horizontal axis of FIG. 14 is wavelength (nm), and the vertical axis of FIG. 14 is transmittance (%).
図 1の実線:スライドガラス  Solid line in Fig. 1: Slide glass
図 1の破線: PETフィルム  Dashed line in Figure 1: PET film
図 2の太 、実線:実施例 3の組成物をスライドガラスに挟み込んで硬化させたもの の透過率  Thick and solid line in FIG. 2: transmittance of the composition of Example 3 sandwiched between glass slides and cured.
図 2の破線:実施例 4の組成物をスライドガラスに挟み込んで硬化させたものの透 過率  Dashed line in Fig. 2: Permeability of the composition of Example 4 sandwiched between glass slides and cured
図 2の 1点破線:実施例 5の組成物をスライドガラスに挟み込んで硬化させたもの の透過率  One-dot broken line in Fig. 2: The transmittance of the composition of Example 5 sandwiched between glass slides and cured.
図 2の細い実線:比較例 1の組成物をスライドガラスに挟み込んで硬化させたもの の透過率  Thin solid line in Fig. 2: Transmittance of the composition of Comparative Example 1 sandwiched between glass slides and cured
図 3の太い実線:実施例 3の組成物を PMMA上で硬化させたものの透過率 図 3の細い実線:比較例 2の組成物を PMMA上で硬化させたものの透過率 図 3の破線:比較例 3の組成物を PMMA上で硬化させたものの透過率 図 4の太 、実線:実施例 3の組成物を PMMA上で硬化させたものの透過率 図 4の細 、実線:比較例 4の組成物を PMMA上で硬化させたものの透過率 図 4の破線:比較例 5の組成物を PMMA上で硬化させたものの透過率 発明を実施するための最良の形態 Thick solid line in Fig. 3: transmittance of the composition of Example 3 cured on PMMA Thin solid line in Fig. 3: Transmittance of the composition of Comparative Example 2 cured on PMMA Fig. 3 Dashed line: Transmittance of the composition of Comparative Example 3 cured on PMMA Thick solid line in Fig. 4 Transmittance of the composition obtained by curing the composition of Example 3 on PMMA Thin and solid line in FIG. 4: Transmittance of the composition obtained by curing the composition of Comparative Example 4 on PMMA Dashed line in FIG. 4: Composition of Comparative Example 5 Of PMMA cured on PMMA Best mode for carrying out the invention
[0033] 以下、本発明を詳細に説明する。 Hereinafter, the present invention will be described in detail.
本発明の紫外線硬化型組成物は、少なくとも一種の下記式(1)で表される化合物、 The ultraviolet-curable composition of the present invention comprises at least one compound represented by the following formula (1),
2個以上のカチオン重合性基を有する化合物 Aおよび光力チオン重合開始剤を含む ことを特徴とする。本発明の紫外線硬化型組成物は、カチオン重合性の榭脂を形成 する。 It is characterized by comprising a compound A having two or more cationically polymerizable groups and a photoinitiated thione polymerization initiator. The ultraviolet-curable composition of the present invention forms a cationically polymerizable resin.
[0034] [化 9] [0034] [Formula 9]
Figure imgf000010_0001
Figure imgf000010_0001
[0035] 式(1)において、 R1は水素原子またはメチル基を表し、 nは 0— 20の整数を表し、 B は炭素数 1一 6のアルキル基、炭素数 1一 6のアルコキシ基、または、ハロゲン原子を 表し、 Bの置換基数 Lは 0— 5までの整数を表し、 Bの置換基数 mは 0— 4までの整数 を表し、また、 Zは下記式(2)または下記式(3)を表す。 In the formula (1), R 1 represents a hydrogen atom or a methyl group, n represents an integer of 0 to 20, B represents an alkyl group having 1 to 6 carbon atoms, an alkoxy group having 1 to 6 carbon atoms, Or, represents a halogen atom, the number L of substituents of B represents an integer from 0 to 5, the number m of substituents of B represents an integer from 0 to 4, and Z represents the following formula (2) or the following formula ( Represents 3).
[0036] [化 10]  [0036] [Formula 10]
Figure imgf000010_0002
Figure imgf000010_0002
[0037] 式(2)にお 、て、 R2は水素原子または炭素数 1一 6個のアルキル基を表す。 [0038] [化 11] In the formula (2), R 2 represents a hydrogen atom or an alkyl group having 116 carbon atoms. [0038] [Formula 11]
O ( 3 ) O (3)
[0039] 式(3)にお 、て、 R3は水素原子またはメチル基を表す。 In the formula (3), R 3 represents a hydrogen atom or a methyl group.
[0040] また、本発明の化合物は、下記式 (4)で表され、式 (4)で表される化合物は、カチ オン重合に好適に用いることができる。  The compound of the present invention is represented by the following formula (4), and the compound represented by the formula (4) can be suitably used for cation polymerization.
[0041] [化 12] [0041]
Figure imgf000011_0001
Figure imgf000011_0001
[0042] 式 (4)にお 、て、 R1は水素原子またはメチル基を表し、 R2は水素原子または炭素 数 1一 6個のアルキル基を表し、 nは 0— 20の整数を表し、 Bは炭素数 1一 6のアルキ ル基、炭素数 1一 6のアルコキシ基、または、ハロゲン原子を表し、 Bの置換基数 Lは 0— 5までの整数を表し、 Bの置換基数 mは 0— 4までの整数を表す。 [0042] In the formula (4), R 1 represents a hydrogen atom or a methyl group, R 2 represents a hydrogen atom or an alkyl group having 116 carbon atoms, and n represents an integer of 0-20. And B represents an alkyl group having 16 carbon atoms, an alkoxy group having 16 carbon atoms, or a halogen atom, the number of substituents L of B represents an integer from 0 to 5, and the number m of substituents m of B is Represents an integer from 0 to 4.
[0043] 式 (4)で表される化合物は、式(1)で表される化合物の Zが式(2)である化合物で ある。よって、式 (4)で表される化合物についての説明を省略する。  The compound represented by the formula (4) is a compound represented by the formula (1), wherein Z of the compound is the formula (2). Therefore, description of the compound represented by the formula (4) is omitted.
[0044] 〇式(1)で表される化合物  [0044] 化合物 Compound represented by formula (1)
式(1)の nは 0— 20の整数を表すが、好ましくは 0— 5、特に好ましくは 0である。 nが 20以下であると、ビフ ニル骨格の濃度が高ぐ硬化物の黄変を低減する効果が高 いので好ましい。特に、式(1)の nが 0の場合は、黄変低減の効果が高いだけでなぐ 原料力 ¾= 1以上のものに比べて安価であり、また式(2)または式(3)の導入が容易 となるため、この点からも特に好ましい。  N in the formula (1) represents an integer of 0 to 20, preferably 0 to 5, and particularly preferably 0. When n is 20 or less, the effect of reducing the yellowing of the cured product with a high concentration of the biphenyl skeleton is high, which is preferable. In particular, when n in the formula (1) is 0, the effect of reducing yellowing is not only high, but the raw material power is cheaper than that of の も の = 1 or more, and the formula (2) or the formula (3) It is particularly preferable from this point because the introduction is easy.
[0045] 上記式(1)の Bは、芳香環上の任意の位置における一価の置換基を表し、 Bの置 換基数 Lは 0— 5までの整数を表し、 Bの置換基数 mは 0— 4までの整数を表す。In the above formula (1), B represents a monovalent substituent at any position on the aromatic ring, The number of substituents L represents an integer from 0 to 5, and the number of substituents m of B represents an integer from 0 to 4.
Bは好ましくは炭素数 1一 6のアルキル基、炭素数 1一 6のアルコキシ基、または、ハ ロゲン原子を表し、式(1)で表される化合物のカチオン重合性を阻害しない限り、他 の任意の一価の置換基を選択することができる。アルキル基およびアルコキシ基は 分岐を有していてもよい。また、ハロゲン原子としては、フッ素原子、塩素原子、臭素 原子、ヨウ素原子が挙げられる。 B preferably represents an alkyl group having 16 carbon atoms, an alkoxy group having 16 carbon atoms, or a halogen atom, and is not limited to other groups as long as the cationic polymerization of the compound represented by the formula (1) is not inhibited. Any monovalent substituent can be selected. The alkyl group and the alkoxy group may have a branch. Further, examples of the halogen atom include a fluorine atom, a chlorine atom, a bromine atom and an iodine atom.
これらの中でも、メチル基、メトキシ基、フッ素原子、臭素原子が好ましぐメチル基 が特に好ましい。  Among them, a methyl group, a methoxy group, a methyl group which is preferably a fluorine atom or a bromine atom is particularly preferable.
mおよび Lが 0の場合は、芳香環上に Bがないことを表し、 mが 1一 4の場合は、芳 香環上に Bがそれぞれ 1一 4つ結合していることを表し、 Lが 1一 5の場合には、芳香 環上に Bがそれぞれ 1一 5つ結合して 、ることを表す。芳香環に置換して 、る L個の B および m個の Bはそれぞれ同じ置換基でもよぐまた異なる置換基であってもよぐそ れぞれ独立に選択することができる。  When m and L are 0, it means that there is no B on the aromatic ring; when m is 1 to 4, it means that there are 1 to 4 B's bonded to the aromatic ring, respectively, L In the case where is 1 to 5, it means that B is bonded to each of 5 to 5 on the aromatic ring. When substituted on the aromatic ring, L B and m B can be independently selected from the same or different substituents.
式(1)の Lおよび mは、好ましくは 0または 2である。式(1)の Lおよび mが 2のときは 、 3, 5, 3,, 5,位に結合しているものが好ましい。  L and m in the formula (1) are preferably 0 or 2. When L and m in the formula (1) are 2, those bonded to the 3, 5, 3, 5, and 5 positions are preferred.
[0046] 式(1)で表される化合物の Zは、式(2)または式(3)で表される力 Zは式(2)で表さ れるォキセタン環を有することが好まし 、。 [0046] Z of the compound represented by the formula (1) is preferably a force Z represented by the formula (2) or (3), and preferably has an oxetane ring represented by the formula (2).
本発明の上記式(1)におけるォキセタ-ル基またはエポキシ基を有する化合物の 結合位置は、 2位、 3位または 4位であり、好ましくは 2位または 4位である。  The bonding position of the compound having an oxetal group or an epoxy group in the above formula (1) of the present invention is at the 2-, 3- or 4-position, preferably at the 2- or 4-position.
[0047] 式(1)で表される化合物は、式(5)で表わされる化合物と式 (6)で表されるォキセタ ン化合物または式 (8)で表されるエポキシィ匕合物とをアルカリ存在下で反応させて得 ることができる。本反応において必要であれば溶媒を用いてもよい。また、相間移動 触媒を用いても良い。 [0048] [化 13] [0047] The compound represented by the formula (1) is obtained by converting the compound represented by the formula (5) and the oxetane compound represented by the formula (6) or the epoxy conjugate represented by the formula (8) to an alkali. It can be obtained by reacting in the presence. A solvent may be used if necessary in this reaction. Further, a phase transfer catalyst may be used. [0048]
Figure imgf000013_0001
Figure imgf000013_0001
[0049] 式(5)にお 、て、 R1は水素原子またはメチル基を表し、 nは 0— 20の整数を表し、 B は炭素数 1一 6のアルキル基、炭素数 1一 6のアルコキシ基、または、ハロゲン原子を 表し、 Bの置換基数 Lは 0— 5までの整数を表し、 Bの置換基数 mは 0— 4までの整数 を表す。 In the formula (5), R 1 represents a hydrogen atom or a methyl group, n represents an integer of 0 to 20, B represents an alkyl group having 1 to 6 carbon atoms, and B represents an alkyl group having 1 to 16 carbon atoms. Represents an alkoxy group or a halogen atom, the number of substituents L of B represents an integer from 0 to 5, and the number of substituents m of B represents an integer from 0 to 4.
[0050] [化 14]  [0050] [Formula 14]
Figure imgf000013_0002
Figure imgf000013_0002
[0051] 式(6)において、 R2は水素原子または炭素数 1一 6個のアルキル基を表す。 In the formula (6), R 2 represents a hydrogen atom or an alkyl group having 116 carbon atoms.
[0052] [化 15] [0052] [Formula 15]
Figure imgf000013_0003
Figure imgf000013_0003
[0053] 式(8)にお 、て、 R3は水素原子またはメチル基を表す。 [0053] Te you, the equation (8), R 3 represents a hydrogen atom or a methyl group.
[0054] 式(1)で表される化合物において、 η力 O以外のものは、 2 フエ-ルフヱノール、 3— フエ-ルフエノール若しくは 4 フエ-ルフエノール並びにそれらの核置換体にェチレ ンオキサイドまたはプロピレンオキサイドを付加さたもの(式(5)で表される化合物)か ら合成することができる。なお、式(1)で表される化合物の nの数については、付加さ せるエチレンオキサイドまたはプロピレンオキサイドの量をコントロールすることで制御 することができる。 [0054] In the compound represented by the formula (1), those other than η-force O are 2-phenylphenol, 3-phenylphenol or 4-phenylphenol, and their nucleus-substituted products are ethylene oxide or propylene oxide. (Compound represented by the formula (5)). The number of n in the compound represented by the formula (1) is controlled by controlling the amount of ethylene oxide or propylene oxide to be added. can do.
また、原料のフエ-ルフヱノールのフエ-ル核に置換基 Bを公知の方法により導入 することができ、例えばフリーデルクラフツ反応によってメチル基などを導入すること ができる。  Further, the substituent B can be introduced into the nucleus of the raw material phenol by a known method, for example, a methyl group can be introduced by a Friedel-Crafts reaction.
なお、式(1)で表される化合物が単一の化合物である場合、 nは整数であるが、 nの 数の異なるものの混合物である場合には、 nを小数点を有する数字で表すこともある 。この場合は、 nは、式(1)で表される化合物の nの数が異なるものの混合物の平均 値を表す。  When the compound represented by the formula (1) is a single compound, n is an integer, but when it is a mixture of different numbers of n, n may be represented by a number having a decimal point. is there . In this case, n represents the average value of a mixture of compounds represented by the formula (1) having different numbers of n.
[0055] 本発明に用いられる式(6)で表されるォキセタン化合物としては、 3 アルキル 3— クロロメチルォキセタンあるいは 3—クロロメチルォキセタンが挙げられる。この 3—アル キル 3—クロロメチルォキセタンとしては、 3—クロロメチルー 3—メチルォキセタン、 3— クロロメチルー 3—ェチルォキセタン、および 3—クロロメチルー 3—プロピルォキセタン等 が挙げられる。本発明においては、 3—アルキル— 3—クロロメチルォキセタンが好まし く、 3—クロロメチルー 3—メチルォキセタン、または 3—クロロメチルー 3—ェチルォキセタ ンがより好ましい。  [0055] Examples of the oxetane compound represented by the formula (6) used in the present invention include 3-alkyl 3-chloromethyloxetane and 3-chloromethyloxetane. Examples of the 3-alkyl 3-chloromethyloxetane include 3-chloromethyl-3-methyloxetane, 3-chloromethyl-3-ethyloxetane, and 3-chloromethyl-3-propyloxetane. In the present invention, 3-alkyl-3-chloromethyloxetane is preferred, and 3-chloromethyl-3-methyloxetane or 3-chloromethyl-3-ethyloxetane is more preferred.
[0056] 本発明にお 、て、式(5)で表される化合物と式 (6)または式 (8)で表される化合物 力も式(1)で表される化合物を合成するときに用いるアルカリとしては、アルカリ金属 、アルカリ金属の水酸化物、アルカリ金属の炭酸塩、アルカリ土類金属の水酸化物、 アルカリ土類金属の炭酸塩およびアルカリ金属水素化物等が挙げられ、好ましくはァ ルカリ金属、アルカリ金属の水酸化物、またはアルカリ金属水素化物である。このァ ルカリとしては、複数のものを併用しても良い。この合成に用いられるアルカリの具体 例としては水酸ィ匕ナトリウム、水酸ィ匕カリウム、水酸化リチウム、水酸ィ匕カルシウム、炭 酸ナトリウム、炭酸カリウム、水素化ナトリウム、水素化カリウム、金属ナトリウム、および 金属カリウム等である。これらの中でも、短時間で十分な転ィ匕率が得られるという理由 力も水酸ィ匕ナトリウムおよび水酸ィ匕カリウムが好ましい。  In the present invention, the compound represented by the formula (5) and the compound represented by the formula (6) or (8) are also used when synthesizing the compound represented by the formula (1). Examples of the alkali include an alkali metal, an alkali metal hydroxide, an alkali metal carbonate, an alkaline earth metal hydroxide, an alkaline earth metal carbonate, and an alkali metal hydride. Metal, alkali metal hydroxide or alkali metal hydride. A plurality of these alkalis may be used in combination. Specific examples of alkalis used in this synthesis include sodium hydroxide, potassium hydroxide, lithium hydroxide, calcium hydroxide, sodium carbonate, potassium carbonate, sodium hydride, potassium hydride, and sodium metal. , And metallic potassium. Among these, sodium hydroxide and potassium hydroxide are preferred also because of the reason that a sufficient transfer ratio can be obtained in a short time.
[0057] 前記アルカリの使用量は、 1モルの式(5)で表される化合物に対して 1モル以上が 好ましぐ 1一 8モル用いることが更に好ましぐ特に好ましくは 1一 2モルである。なお 、後処理のことを考慮して 1モルの式(5)で表される化合物に対し前記アルカリを 1モ ル未満用いることもできる。またアルカリの水溶液または水懸濁液として用いる場合に おけるアルカリの濃度は 1一 96重量%のものが好ましぐさらに好ましくは 20— 96重 量%である。 [0057] The amount of the alkali to be used is preferably 1 mol or more, more preferably 18 mol, particularly preferably 1 mol, to 1 mol of the compound represented by the formula (5). It is. In consideration of the post-treatment, one mole of the alkali is added to one mole of the compound represented by the formula (5). Can be used. When used as an aqueous solution or suspension of an alkali, the alkali concentration is preferably from 1 to 96% by weight, more preferably from 20 to 96% by weight.
水酸ィ匕アルカリ金属としては、好ましくは、 5— 60重量%水溶液あるいは粉末状に した水酸ィ匕ナトリウム或いは水酸ィ匕カリウム等が用いられ、より好ましくは、 40— 50重 量%水溶液のものが用いられる。  As the alkali metal hydroxide, preferably, a 5-60% by weight aqueous solution or a powdered sodium hydroxide or potassium hydroxide is used, and more preferably, a 40-50% by weight aqueous solution. Is used.
[0058] 式(1)で表される化合物の合成に用いるときの溶媒としては、原料および反応生成 物に対して不活性な溶媒を用いることができる。この溶媒は、合成する時に系内で生 成する水と共沸する溶媒が望ましい。この溶媒としては、ベンゼン、トルエン、キシレ ン、ェチルベンゼン、メチルシクロへキサン、ェチルシクロへキサン、 n—ブチノレエーテ ル等があげられる。合成系内で生成した水を溶媒と共に留出させることにより、反応 時間を短縮することができる。この溶媒の量としては、反応器内における原料および 反応生成物の合計 1重量部に対して 0. 05— 100重量部が好ましぐさらに好ましく は 0. 1— 20重量部である。溶媒の量が上記範囲内であると、単位容積当たりの収量 が高ぐ溶媒の回収に力かるエネルギーが少なぐ経済的であるので好ましい。式(1 )で表される化合物の合成にはトルエン、キシレン、メチルシクロへキサン、ェチルシ クロへキサン等が好適に用いられる。 [0058] As a solvent for use in synthesizing the compound represented by the formula (1), a solvent inert to the raw materials and the reaction products can be used. This solvent is preferably a solvent that azeotropes with water generated in the system during synthesis. Examples of the solvent include benzene, toluene, xylene, ethylbenzene, methylcyclohexane, ethylcyclohexane, n-butynoleatel and the like. The reaction time can be reduced by distilling the water generated in the synthesis system together with the solvent. The amount of the solvent is preferably 0.05 to 100 parts by weight, more preferably 0.1 to 20 parts by weight, based on 1 part by weight of the total of the raw material and the reaction product in the reactor. When the amount of the solvent is within the above range, the yield per unit volume is high, the energy for recovering the solvent is small, and it is economical. For the synthesis of the compound represented by the formula (1), toluene, xylene, methylcyclohexane, ethylcyclohexane and the like are suitably used.
[0059] 式(1)で表される化合物の合成において用いることができる相間移動触媒としては 、公知の相間移動触媒 (例えば、 W. P. Weber, G. W. Gokel共著、田伏岩夫、西 谷孝子共訳「相間移動触媒」、(株)化学同人発行等に記載のもの)の!、ずれも用い ることができる。これらの中でも触媒としての能力の高さから、有機第 4級アンモ-ゥム 塩およびホスホ-ゥム塩が好ましい。具体例としては、テトラー n—ブチルアンモ -ゥム ブロミド、ベンジルトリェチルアンモ-ゥムブロミド、トリオクチルメチルアンモ -ゥムクロ リド、テトラー n—ブチルホスホ-ゥムクロリド、トリオクチルェチルホスホ-ゥムブロミドぉ よびテトラフエ-ルホスホ -ゥムクロリド等が挙げられる。  As the phase transfer catalyst that can be used in the synthesis of the compound represented by the formula (1), known phase transfer catalysts (for example, WP Weber, GW Gokel, Iwao Tabushi, Takako Nishitani, “ ! (Shift catalyst) and those described in “Chemical Doujin Co., Ltd.) can also be used. Among these, organic quaternary ammonium salts and phosphonium salts are preferred because of their high catalytic ability. Specific examples include tetra-n-butylammonium-bromobromide, benzyltriethylammonium-bromobromide, trioctylmethylammo-bromochloride, tetra-n-butylphospho-bromochloride, trioctylethylphospho-pambromide and tetraphenylphospho-bromochloride. And the like.
[0060] 式(1)で表される化合物を合成する時の反応温度は、好ましくは 80— 150°Cであり 、特に好ましくは 100— 120°Cである。式(1)で表される化合物を合成する時の反応 時間は、反応温度や相間移動触媒の使用の有無にもよるが、 4一 50時間が好ましい [0061] 反応終了後は、室温まで冷却した反応液を、水洗および蒸留等を行うことにより、 式(1)で表される目的とする化合物(目的物)を得ることができる。目的物は、 JH-N MRおよび13 C— NMRスペクトルによって確認できる。 [0060] The reaction temperature at the time of synthesizing the compound represented by the formula (1) is preferably from 80 to 150 ° C, particularly preferably from 100 to 120 ° C. The reaction time for synthesizing the compound represented by the formula (1) depends on the reaction temperature and whether or not a phase transfer catalyst is used, but is preferably 4 to 50 hours. After the completion of the reaction, the reaction solution cooled to room temperature is washed with water, distilled, and the like, whereby the target compound (target substance) represented by the formula (1) can be obtained. The desired product can be confirmed by J HN MR and 13 C-NMR spectrum.
[0062] 本発明の式(1)で表される化合物の Zは、式(2)または式(3)である力 組成物の 硬化性から、好ましくは式(2)で表されるものまたは式(3)の R3力メチル基であるもの であり、更に好ましくは式(2)で表される化合物である。 [0062] In the compound of the present invention represented by the formula (1), Z is preferably represented by the formula (2) or from the curability of the power composition represented by the formula (2) or (3) or A compound represented by the formula (3), which is an R 3 methyl group, is more preferably a compound represented by the formula (2).
式(2)の R2は水素原子または炭素数 1一 6個のアルキル基を表し、アルキル基は分 岐を有していてもよい。また、 R2はメチル基またはェチル基であることが好ましい。 R 2 in the formula (2) represents a hydrogen atom or an alkyl group having 116 carbon atoms, and the alkyl group may have a branch. R 2 is preferably a methyl group or an ethyl group.
[0063] なお、本発明の組成物は、式(1)で表される化合物を少なくとも一種含有するが、 R \ R2、 R3および置換基 Bの種類や、 L、 m、 nの数が異なる複数の化合物を混合して 用いても良ぐまた式(1)の Zが異なる化合物を混合して用 、ることもできる。 [0063] The composition of the present invention, but contains at least one compound represented by formula (1), and the kind of R \ R 2, R 3 and substituents B, L, m, n number of It is possible to use a mixture of a plurality of compounds having different formulas, and it is also possible to use a mixture of compounds having different Z in the formula (1).
[0064] また、式(1)で表される化合物が L=m=n=0であって、ォキセタ-ル基またはェ ポキシ基を有する化合物の結合位置が 4位である場合、化合物は室温で固体である 。これに対し、結合位置が 2位である場合、化合物は室温で液体であるため、配合部 数を増やしても組成物は液状である。従って、ォキセタニル基またはエポキシ基を有 する化合物の結合位置が 2位であることが好ましい。  Further, when the compound represented by the formula (1) is L = m = n = 0 and the bond position of the compound having an oxetal group or an epoxy group is the 4-position, the compound is at room temperature. And is solid. On the other hand, when the bonding position is at the 2-position, the compound is liquid at room temperature, so that the composition is liquid even if the number of components is increased. Therefore, it is preferable that the compound having an oxetanyl group or an epoxy group be bonded at the 2-position.
さらに、置換基 Bを有する場合であっても、ォキセタニル基またはエポキシ基を有す る化合物の結合部位は 2位であることが好ましい。  Further, even when the compound has a substituent B, the binding site of the compound having an oxetanyl group or an epoxy group is preferably at the 2-position.
[0065] 本発明の組成物において、式(1)で表される化合物の合計の配合部数は特に限 定するものではないが、カチオン重合性成分を 100重量部として、好ましくは 10— 9 9重量部、さらに好ましくは 20— 90重量部、特に好ましくは 30— 80重量部である。 配合部数が上記範囲内であると、硬化物の黄変を低減する効果が高!、ので好ま 、 。なお、カチオン重合性成分とは、式(1)で表される化合物、 2個以上のカチオン重 合性基を有する化合物 A、および 1個のカチオン重合性基を有する化合物 B等であ る。このカチオン重合性基とは、エポキシ基、ォキセタン基、およびビニルエーテル基 などが挙げられる。  [0065] In the composition of the present invention, the total compounding amount of the compound represented by the formula (1) is not particularly limited, but is preferably from 10 to 99, based on 100 parts by weight of the cationically polymerizable component. Parts by weight, more preferably 20 to 90 parts by weight, particularly preferably 30 to 80 parts by weight. When the blending number is within the above range, the effect of reducing yellowing of the cured product is high! The cationically polymerizable components include a compound represented by the formula (1), a compound A having two or more cationically polymerizable groups, and a compound B having one cationically polymerizable group. Examples of the cationic polymerizable group include an epoxy group, an oxetane group, and a vinyl ether group.
また、式(1)で表される化合物は、硬化物の透明性が要求されない用途に用いるこ とちでさる。 The compound represented by the formula (1) can be used for applications where the transparency of the cured product is not required. I'm sorry.
[0066] 本発明におけるカチオン重合開始剤は、光あるいは熱の適応により活性ィ匕されて 酸成分を生成し、組成物中のカチオン重合性基のカチオン重合を誘発するように作 用するものである。  [0066] The cationic polymerization initiator in the present invention acts so as to generate an acid component by being activated by adaptation of light or heat to induce cationic polymerization of the cationically polymerizable group in the composition. is there.
カチオン重合開始剤としては、光が照射されて活性化され、カチオン重合性基の重 合を誘発し得る任意の光力チオン重合開始剤を用いることが好ましい。また、光増感 剤を併用することもできる。さらに、カチオン重合開始剤としては、加熱により活性ィ匕 され、カチオン重合性基の重合を誘発し得るものであれば、何れの熱カチオン重合 開始剤も用いることができる。  As the cationic polymerization initiator, it is preferable to use any light-powered thione polymerization initiator that is activated by irradiation with light and can induce polymerization of the cationically polymerizable group. Further, a photosensitizer can be used in combination. Further, as the cationic polymerization initiator, any thermal cationic polymerization initiator can be used as long as it is activated by heating and can induce polymerization of the cationically polymerizable group.
[0067] 本発明における光力チオン重合開始剤とは、紫外線の照射によってカチオン重合 させうる酸を発生する化合物のことである。光力チオン重合開始剤としては、ォ -ゥム 塩および有機金属錯体等を例示することができる。 [0067] The photo-thione polymerization initiator in the present invention is a compound that generates an acid capable of undergoing cationic polymerization by irradiation with ultraviolet light. Examples of the photoinitiated thione polymerization initiator include oxalate salts and organometallic complexes.
有機金属錯体類としては、例えば、鉄-アレン錯体、チタノセン錯体およびァリール シラノール アルミニウム錯体等が挙げられる。  Examples of the organometallic complexes include an iron-allene complex, a titanocene complex, and an arylsilanol aluminum complex.
ォ -ゥム塩の具体的な例としては、ジァゾ -ゥム塩、ョードニゥム塩、スルホ -ゥム塩 、セレニウム塩、ピリジ-ゥム塩、フエロセ -ゥム塩、ホスホ-ゥム塩、およびチヲピリ- ゥム塩等が挙げられる。本発明においては、ョードニゥム塩を用いると黄色く着色する ことがあることから、硬化性および黄変性の少なさの点で芳香族スルホ -ゥム塩ゃジ アルキルフエナシルスルホ -ゥム塩等のスルホ -ゥム塩が好ましく、更に好ましくは芳 香族スルホ -ゥム塩であり、特に好ましくはトリアリールスルホ -ゥム塩である。  Illustrative examples of o-pium salts include diazo-pium salt, odonium salt, sulfo-pum salt, selenium salt, pyridi-p-m salt, ferrose-pum salt, phospho-pum salt, and Dipium salt and the like. In the present invention, since the use of a rhododium salt may cause a yellow coloration, sulfode such as an aromatic sulfo-dum salt, dialkylphenacyl sulfo-dum salt or the like is preferred in terms of curability and less yellowing. -Pham salts are preferred, aromatic sulfo-pam salts are more preferred, and triaryl sulfo-pam salts are particularly preferred.
[0068] ョードニゥム塩およびスルホ -ゥム塩等のォ-ゥム塩の光力チオン重合開始剤を本 発明の組成物に使用する場合、ァニオンとしては BF― AsF― [0068] When a photoinitiated thione polymerization initiator such as a rhododium salt or a sulfodium salt is used in the composition of the present invention, the anion is BF-AsF-
4、 6、 SbF―  4, 6, SbF
6、 PF―、および 6 6, PF-, and 6
B (C F )—などが挙げられる力 好ましくは SbF—および PF—などである。 B (C F) — and the like. Preferred are SbF— and PF—.
6 5 4 6 6  6 5 4 6 6
[0069] 市販のトリアリールスルホ -ゥム塩としては、ダウ'ケミカル日本 (株)製の、サイラキュ ァー UVI— 6990、 UVI— 6992、および UVI— 6974や、旭電化工業 (株)製のアデ力 ォプトマ一 SP— 150、 SP— 152、 SP— 170、および SP— 172等、和光純薬工業 (株) 製の WP AG— 593、 WPAG—596、 WPAG—640、および WP AG— 641等が挙げら れ、本発明に使用できる。 [0070] 市販の芳香族ョードニゥム塩としては、 GE東芝シリコーン社製 UV— 9380C、ロー ディア社製 PHOTOINITIATOR2074、和光純薬工業 (株)製 WPI— 116、 WPI - 1 13および CD— 1012 (商品名、サートマ一社製)等が挙げられる。 [0069] Commercially available triarylsulfo-pium salts include Cyracure UVI-6990, UVI-6992, and UVI-6974 manufactured by Dow Chemical Japan, and Asahi Denka Kogyo Co., Ltd. Adeki Optomatic SP-150, SP-152, SP-170, SP-172, etc., WP AG-593, WPAG-596, WPAG-640, WP AG-641, etc. manufactured by Wako Pure Chemical Industries, Ltd. And can be used in the present invention. [0070] Commercially available aromatic rhododium salts include UV-9380C manufactured by GE Toshiba Silicone, PHOTOINITIATOR2074 manufactured by Rhodia, WPI-116, WPI-113 and CD-1012 manufactured by Wako Pure Chemical Industries, Ltd. (trade names) And Sartoma Co., Ltd.).
[0071] これらのうち、硬化性と黄変性の低さの点で、 UVI— 6990および UVI— 6992が特 に好ましい。  [0071] Among these, UVI-6990 and UVI-6992 are particularly preferred in terms of curability and low yellowing.
[0072] 本発明における光力チオン重合開始剤の配合量は、紫外線の種類や照射量に応 じて適宜に調整できる。例えばカチオン重合性成分 100重量部に対し、 0. 01— 5重 量部とすることが好ましぐ 0. 1一 5重量部とすることがより好ましぐ特に好ましくは 1 一 3部である。光力チオン重合開始剤の配合量が上記範囲内であると、十分な硬化 性が得られると共に、重合後の耐熱性および低吸水性等も十分であるので好まし ヽ 。また、硬化に真に必要な成分の量が減少することがなぐ硬化物の物性の低下や、 硬化物の黄変、耐熱性等の他の特性が低下することがな 、ので好ま 、。  [0072] The blending amount of the photo-induced thione polymerization initiator in the present invention can be appropriately adjusted according to the type and irradiation amount of ultraviolet rays. For example, with respect to 100 parts by weight of the cationically polymerizable component, 0.01 to 5 parts by weight is preferable, 0.1 to 5 parts by weight is more preferable, and 13 to 13 parts by weight is particularly preferable. . It is preferable that the amount of the photoinitiated thione polymerization initiator be within the above range, since sufficient curability can be obtained, and heat resistance after polymerization and low water absorption are also sufficient. In addition, it is preferable because the physical properties of the cured product are not reduced without reducing the amount of components truly required for curing, and other characteristics such as yellowing and heat resistance of the cured product are not reduced.
[0073] 本発明の組成物には、光力チオン重合開始剤の活性を高めるため、増感剤を併用 することもできる。本発明で用いることができる増感剤として、クリベロがアドバンスド イン ポリマーサイエンス(Adv. in Plymer Sci. , 62, 1 (1984) )で開示してい る化合物を用いることが可能である。具体的には、ピレン、ペリレン、アタリジンオレン ジ、チォキサントン、 2—クロ口チォキサントンおよびペンゾフラビン等がある。  [0073] A sensitizer may be used in combination with the composition of the present invention in order to increase the activity of the photoinitiated thione polymerization initiator. As the sensitizer that can be used in the present invention, it is possible to use a compound disclosed by Krivero in Advanced in Polymer Science (Adv. In Plymer Sci., 62, 1 (1984)). Specific examples include pyrene, perylene, atalidine orange, thioxanthone, 2-cloth thioxanthone, and benzoflavin.
また、光ラジカル重合開始剤として広く使用されている化合物も使用することができ 、特に、本発明の組成物に、分子中にラジカル重合性基を有する化合物を配合した ときは、ラジカル重合開始剤を添加することもできる。このラジカル重合開始剤とは、 熱、光、あるいはレドックス反応等によりラジカルを発生する化合物を例示できる。こ のようなものとしては、有機過酸化物、ァゾィ匕合物、レドックス開始剤等が挙げられる 。具体的には、ベンゾフエノン、 2, 4 ジェチルチオキサントン、 2 イソプロピルチオ キサントン、 2, 4ージクロ口チォキサントン等のチォキサントン類、ベンゾインメチルェ 一テル、ベンゾインェチルエーテル、ベンゾインイソプロピルエーテル等のベンゾイン エーテル類、 2, 2—ジメトキシー 1, 2—ジフエ-ルェタン 1 オン等のベンジルジメチ ルケタール類、 2—ヒドロキシー 2—メチルー 1 フエ-ルプロパン— 1 オン、 1— (4 イソ プロピルフエ-ル)—2—ヒドロキシー 2—メチルプロパン 1 オン、 1ーヒドロキシシクロへ キシルフエ-ルケトン等の α—ヒドロキシアルキルフエノン類、カンファーキノン等の α ージカルボ-ルイ匕合物等が挙げられる。 Further, a compound widely used as a photo-radical polymerization initiator can also be used. Particularly, when a compound having a radical-polymerizable group in a molecule is added to the composition of the present invention, the radical polymerization initiator is used. Can also be added. Examples of the radical polymerization initiator include compounds that generate a radical by heat, light, a redox reaction, or the like. Examples of such a substance include an organic peroxide, an azoi compound, a redox initiator, and the like. Specifically, benzoxanone such as benzophenone, 2,4 getylthioxanthone, 2 isopropylthioxanthone, 2,4 dichloromouth thioxanthone, benzoin ether such as benzoin methyl ether, benzoin ethyl ether, benzoin isopropyl ether, Benzyldimethyl ketals such as 2,2-dimethoxy-1,2-diphenyl-1-one, 2-hydroxy-2-methyl-1-phenylpropane-1 on, 1- (4-isopropylpropyl) -2-hydroxy-2- To methyl propane 1 on, 1-hydroxycyclo Α-Hydroxyalkylphenones such as xylphenol ketone; α-dicarboxylic conjugates such as camphorquinone; and the like.
[0074] しかし、本発明の組成物においては、この硬化物の黄変を低減できることから、光力 チオン重合開始剤としてスルホ -ゥム塩を使用し、かつ増感剤を使用しな ヽものが好 ましい。 [0074] However, in the composition of the present invention, since the yellowing of the cured product can be reduced, a sulfo-dimethyl salt is used as a photothione polymerization initiator and no sensitizer is used. Is preferred.
[0075] 本発明の組成物において、これを硬化させる時に使用する紫外線の波長範囲は特 に限定されないが、硬化性と黄変性の少なさの双方を考慮すると、好ましくは 200— 380nmである。黄変性の少なさのみを重視する場合、好ましくは 300— 380nm、特 に好ましくは 320— 380nmである。  [0075] In the composition of the present invention, the wavelength range of ultraviolet light used for curing the composition is not particularly limited, but is preferably 200 to 380 nm in consideration of both curability and low yellowing. When importance is placed solely on the small amount of yellowing, it is preferably from 300 to 380 nm, particularly preferably from 320 to 380 nm.
[0076] また、活性エネルギー線により重合を行う場合に用いることのできる光源としては特 に限定されるものではないが、波長 400nm以下に発光分布を有する、例えば、低圧 水銀灯、中圧水銀灯、高圧水銀灯、超高圧水銀灯、ケミカルランプ、ブラックライトラ ンプ、マイクロウエーブ励起水銀灯およびメタルノヽライドランプ等を用いることができる 。組成物への光照射強度は、目的とする製品毎に制御されるものであって特に限定 されるものではな ヽが、光潜在性を有するカチオン重合開始剤の活性化に有効な光 波長領域(当該重合開始剤によって異なる)の光照射強度が 0. 1-lOOmW/cm2 であることが好ましい。組成物への光照射強度が上記範囲内であると、反応時間が 適当であるので好ま 、。またランプ力 輻射される熱および組成物の重合時の発熱 により、得られる硬化物の凝集力の低下や黄変あるいは支持体の劣化を生じることが ないので好ましい。組成物への光照射時間は、目的とする製品毎に制御されるもの であって特に限定されるものではないが、前記光波長領域での光照射強度と光照射 時間の積として表される積算光量が 10— 5, OOOmi/cm2となるように設定されること が好ましい。上記組成物の積算光量が上記範囲内であると、当該開始剤からの活性 種の発生が充分で、得られる硬化物の特性の低下を生じることがな 、ので好ま 、。 また、照射時間が短ぐ生産性が向上するので好ましい。また、活性エネルギー線の 照射後 0. 1—数分後には、ほとんどの組成物はカチオン重合により指触乾燥するが 、カチオン重合の反応を促進するために加熱を併用することも場合によっては好まし い。 [0077] 本発明の組成物に配合する 2個以上のカチオン重合性基を有する化合物 Aは、力 チオン重合性基が好ましくは 10以下であり、より好ましくは 5以下である。この 2個以 上のカチオン重合性基を有する化合物 Aとしては、エポキシ基を有する化合物 A、ォ キセタ二ル基を有する化合物 A、およびビニルエーテル基を有する化合物 Aを挙げ ることができ、これらの混合物を用いることができる。なお、 2個以上のカチオン重合 性基を有する化合物 Aとしては、密着性を重視する場合は 2官能のグリシジルエーテ ル型のエポキシ化合物が好ましぐ硬化性を重視する場合は 2官能以上の脂環式ェ ポキシィ匕合物および Zまたはォキセタン化合物が好ましい。また、ガラス転移温度以 上での弾性率を向上させる場合は 3官能以上が好ましい。 [0076] The light source that can be used in the case of performing polymerization using an active energy ray is not particularly limited, but has a light emission distribution at a wavelength of 400 nm or less, such as a low-pressure mercury lamp, a medium-pressure mercury lamp, and a high-pressure mercury lamp. Mercury lamps, ultra-high pressure mercury lamps, chemical lamps, black light lamps, microwave-excited mercury lamps, metal halide lamps, and the like can be used. The light irradiation intensity of the composition is controlled for each target product and is not particularly limited.However, the light wavelength range effective for activating the cationic photoinitiator having photolatitude is used. It is preferable that the light irradiation intensity (depending on the polymerization initiator) is 0.1-100 mW / cm 2 . It is preferable that the light irradiation intensity of the composition be within the above range, since the reaction time is appropriate. Further, it is preferable because the heat irradiated by the lamp power and the heat generated during the polymerization of the composition do not cause a decrease in cohesive strength, yellowing or deterioration of the support of the obtained cured product. The light irradiation time for the composition is controlled for each target product and is not particularly limited, and is expressed as a product of the light irradiation intensity and the light irradiation time in the light wavelength region. It is preferable that the integrated light amount is set to be 10-5, OOOmi / cm 2 . When the integrated light amount of the composition is within the above range, the generation of the active species from the initiator is sufficient, and the characteristics of the obtained cured product are not deteriorated. Further, the irradiation time is short, which is preferable since productivity is improved. In addition, most of the compositions are dried to the touch by cationic polymerization 0.1 to several minutes after the irradiation with the active energy ray, but it is sometimes preferable to use heating in combination to promote the cationic polymerization reaction. Better. [0077] The compound A having two or more cationically polymerizable groups to be blended in the composition of the present invention preferably has 10 or less, more preferably 5 or less, thiothionizable groups. Examples of the compound A having two or more cationically polymerizable groups include a compound A having an epoxy group, a compound A having an oxetanol group, and a compound A having a vinyl ether group. Mixtures can be used. As the compound A having two or more cationically polymerizable groups, a bifunctional glycidyl ether-type epoxy compound is preferred when adhesion is important, and a difunctional or higher functional epoxy compound is preferred when curability is preferred. Preferred are cyclic epoxy conjugates and Z or oxetane compounds. When the elastic modulus at or above the glass transition temperature is to be improved, trifunctional or higher is preferred.
化合物 Aは、本発明の組成物のカチオン重合性基を含む化合物成分 100重量部 に対して 1一 80重量部含有されていることが好ましぐ 5— 60重量部含有されている ことがより好ましぐ 10— 50重量部含有されていることがさらに好ましい。  The compound A is preferably contained in an amount of 1 to 80 parts by weight, more preferably 5 to 60 parts by weight, based on 100 parts by weight of the compound component containing a cationically polymerizable group of the composition of the present invention. More preferably, it is contained in an amount of 10 to 50 parts by weight.
[0078] エポキシ基を有する化合物 Aとしては、ジシクロペンタジェンジオキサイド、リモネン ジオキサイド、 4 ビュルシクロへキセンジオキサイド、 3, 4 エポキシシクロへキシルメ チノレー 3, 4—エポキシシクロへキサン力ノレボキシレート、ジ(3, 4—エポキシシクロへキ シル)アジペート、ビスフエノール A型エポキシ榭脂(ビスフエノール Aジグリシジルェ 一テル)、ハロゲン化ビスフエノール A型エポキシ榭脂、水素添カ卩ビスフエノール A型 エポキシ榭脂、ビスフエノール Sジグリシジルエーテル、ハロゲン化ビスフエノール Sジ グリシジルエーテル、水素添カ卩ビスフエノール Sジグリシジルエーテル、ビスフエノー ル F型エポキシ榭脂、ハロゲン化ビスフエノール F型エポキシ榭脂、水素添加ビスフエ ノール F型エポキシ榭脂、 1, 6—へキサンジオールジグリシジルエーテル、ポリテトラメ チレングリコールジグリシジルエーテル、ポリブタジエンの両末端がグリシジルエーテ ル化された化合物、 o—、 m—、 p—クレゾ一ルノボラック型エポキシ榭脂ゃフヱノールノ ポラック型エポキシ榭脂等のエポキシノボラック榭脂、トリメチロールプロパントリグリシ ジルエーテル、ペンタエリスリトールテトラグリシジルエーテル、 3, 4—エポキシシクロ へキシルメチルー 3' , 4' エポキシシクロへキサンカルボキシルレート、 2—(3, 4—ェ ポキシシクロへキシノレ 5, 5—スピロ 3, 4—エポキシ)シクロへキサン メタージォキサ ン、ビス(3, 4—エポキシシクロへキシルメチル)アジペート、ビス(3, 4—エポキシ 6— メチルシクロへキシルメチル)アジペート、 3, 4 エポキシ 6—メチルシクロへキシルー 3' , 4' エポキシ 6'—メチルシクロへキサンカルボキシルレート、メチレンビス(3, 4 エポキシシクロへキサン)、ジシクロペンタジェンジェポキサイド、エチレングリコール のジ(3, 4—エポキシシクロへキシルメチル)エーテル、エチレンビス(3, 4—エポキシ シクロへキサンカルボキシルレート)、 1, 4 ブタンジオールジグリシジルエーテル、 1 , 6—へキサンジオールジグリシジルエーテル、グリセリントリグリシジルエーテル、ポリ エチレングリコールジグリシジルエーテル、ポリプロピレングリコールジグリシジルエー テル類、;エチレングリコール、プロピレングリコール、グリセリン等の脂肪族多価アル コールに 1種または 2種以上のアルキレンオキサイドを付加することにより得られるポリ エーテルポリオールのポリグリシジルエーテル類;脂肪族長鎖二塩基酸のジグリシジ ルエステル類;ポリブタジエンの内部エポキシ化物、スチレン ブタジエン共重合体の 二重結合が一部エポキシ化された化合物(例えばダイセルィ匕学工業 (株)製ェポフレ ンド)、エチレンーブチレン共重合体とポリイソプレンのブロックコポリマーのポリイソプ レンの一部がエポキシ化された化合物(例えば KRATON社製 L—207)、 4 ビニル シクロへキセンオキサイドの開環重合体のビニル基をエポキシィ匕した構造の化合物( 例えばダイセルィ匕学工業 (株)製 EHPE3150)、およびエポキシ化植物油(エポキシ 化大豆油、エポキシ化アマ-油等)等が例示できる。 [0078] Examples of the compound A having an epoxy group include dicyclopentagendioxide, limonene dioxide, 4-butylcyclohexenedioxide, 3,4 epoxycyclohexylmethylenoleate 3,4-epoxycyclohexanyl ureboxylate, (3,4-epoxycyclohexyl) adipate, bisphenol A epoxy resin (bisphenol A diglycidyl ether), halogenated bisphenol A epoxy resin, hydrogenated bisphenol A epoxy resin , Bisphenol S diglycidyl ether, halogenated bisphenol S diglycidyl ether, hydrogenated phenol bisphenol S diglycidyl ether, bisphenol F type epoxy resin, halogenated bisphenol F type epoxy resin, hydrogenated bisphenol F-type epoxy resin, 1, 6 Hexanediol diglycidyl ether, polytetramethylenglycol diglycidyl ether, compounds in which both ends of polybutadiene are glycidyl etherified, o-, m-, p-cresol novolak epoxy resin and phenol nopolak epoxy resin, etc. Epoxy novolak resin, trimethylolpropane triglycidyl ether, pentaerythritol tetraglycidyl ether, 3,4-epoxycyclohexylmethyl-3 ', 4' epoxycyclohexanecarboxylate, 2- (3,4-epoxycyclo) Xinole 5,5-spiro 3,4-epoxy) cyclohexane metadioxane, bis (3,4-epoxycyclohexylmethyl) adipate, bis (3,4-epoxy 6— Methylcyclohexylmethyl) adipate, 3,4 epoxy 6-methylcyclohexyl 3 ', 4' epoxy 6'-methylcyclohexanecarboxylate, methylenebis (3,4 epoxycyclohexane), dicyclopentadiene epoxide, ethylene Glycol di (3,4-epoxycyclohexylmethyl) ether, ethylenebis (3,4-epoxycyclohexanecarboxylate), 1,4 butanediol diglycidyl ether, 1,6-hexanediol diglycidyl ether, Glycerin triglycidyl ether, polyethylene glycol diglycidyl ether, polypropylene glycol diglycidyl ethers; one or more alkylated aliphatic polyhydric alcohols such as ethylene glycol, propylene glycol, and glycerin; Polyglycidyl ethers of polyether polyols obtained by adding oxides; Diglycidyl esters of aliphatic long-chain dibasic acids; Internal epoxidized products of polybutadiene; Double bonds of styrene-butadiene copolymer were partially epoxidized A compound (eg, Epofrend, manufactured by Daiceli-Dagaku Kogyo Co., Ltd.), a compound obtained by partially epoxidizing a polyisoprene of an ethylenebutylene copolymer and a block copolymer of polyisoprene (eg, L-207 manufactured by KRATON), 4 Compounds having a structure in which the vinyl group of the ring-opened polymer of vinyl cyclohexene oxide is epoxidized (eg, EHPE3150 manufactured by Daiceli Gakugaku Kogyo Co., Ltd.), and epoxidized vegetable oils (epoxidized soybean oil, epoxidized flax oil, etc.) Etc. can be exemplified.
ォキセタニル基を有する化合物 Aとしては (カツコ内は商品名または開発品名、東 亞合成製)、 1, 4 ビス { [ (3—ェチルー 3—ォキセタ -ル)メトキシ]メチル }ベンゼン(ァ ロンォキセタン OXT— 121 (XDO) )、ジ [2—(3—ォキセタ -ル)ブチル]エーテル(ァ ロンォキセタン OXT— 221 (DOX) )、 1, 4 ビス〔(3—ェチルォキセタン 3 ィル)メト キシ〕ベンゼン(HQOX)、 1, 3 ビス〔(3 ェチルォキセタン 3 ィル)メトキシ〕ベン ゼン (RSOX)、 1, 2—ビス〔(3—ェチルォキセタン— 3—ィル)メトキシ〕ベンゼン(CTO χ)、4, 4,一ビス〔(3—ェチルォキセタン— 3—ィル)メトキシ〕ビフエ-ル(4, 4,一 ΒΡΟΧ )、 2, 2,一ビス〔(3—ェチルー 3—ォキセタ -ル)メトキシ〕ビフエ-ル(2, 2,一 ΒΡΟΧ)、 3, 3' , 5, 5'—テトラメチル〔4, 4' ビス(3—ェチルォキセタン 3—ィル)メトキシ〕ビフ ェ-ル(ΤΜ— ΒΡΟΧ)、 2, 7 ビス〔(3 ェチルォキセタン 3 ィル)メトキシ〕ナフタレ ン(2, 7— NpDOX)、 1, 6 ビス〔(3—ェチルォキセタン 3 ィル)メトキシ〕— 2, 2, 3 , 3, 4, 4, 5, 5—才クタフルォ口へキサン(OFH— DOX)、 3 (4) , 8 (9)—ビス [ (1—ェ チルー 3—ォキセタ -ル)メトキシメチル]—トリシクロ [5. 2. 1. 02·6]デカン、 1, 2 ビス { 2— [ (1—ェチルー 3—ォキセタ -ル)メトキシ]ェチルチオ }ェタン、 4, 4,一 As the compound A having an oxetanyl group (in Kazuko, a product name or a product name, manufactured by Toagosei Co., Ltd.), 1,4bis {[(3-ethyl-3-oxeta-l) methoxy] methyl} benzene} aronoxetane OXT— 121 (XDO)), di [2- (3-oxeta-butyl) butyl] ether (aronoxetane OXT-221 (DOX)), 1,4-bis [(3-ethyloxetane-3-yl) methoxy] benzene (HQOX) ), 1,3-bis [(3-ethyloxetane-3-yl) methoxy] benzene (RSOX), 1,2-bis [(3-ethyloxetane-3-yl) methoxy] benzene (CTO II), 4,4, 1-bis [(3-ethyloxetane-3-yl) methoxy] biphenyl (4,4,100), 2,2,1-bis [(3-ethylo-3-oxeta-l) methoxy] biphenyl ( 2, 2, 1ΒΡΟΧ), 3, 3 ', 5, 5'-tetramethyl [4, 4'bis (3-ethyloxetane 3-yl) Methoxy] biphenyl (ΤΜ-ΒΡΟΧ), 2,7-bis [(3-ethyloxetane-3-yl) methoxy] naphthalene (2,7-NpDOX), 1,6-bis [(3-ethyloxetane-3-yl) methoxy ] — 2, 2, 3 , 3,4,4,5,5—year-old octafluorohexane (OFH—DOX), 3 (4), 8 (9) —bis [(1-ethyl) -3-oxeta-l) methoxymethyl] —tricyclo [5.2.1.10 2 · 6 ] decane, 1,2 bis {2-[(1-ethyl-3-oxeta-l) methoxy] ethylthio} ethane, 4,4,1
ビス [ (1ーェチルー 3—ォキセタ -ル)メチル]チォジベンゼンチォエーテル、 2, 3—ビ ス [ (3 ェチルォキセタン— 3 ィル)メトキシメチル]ノルボルナン(NDMOX)、 2—ェ チルー 2— [ (3 ェチルォキセタン— 3 ィル)メトキシメチル]— 1, 3 O ビス [ (1ーェチ ルー 3—ォキセタ -ル)メチル] プロパン 1, 3—ジオール(TMPTOX)、 2, 2 ジメチ ルー 1, 3— O—ビス [ (3—ェチルォキセタン 3 ィル)メチル] プロパン 1, 3—ジォ一 ル(NPGOX)、 2—ブチルー 2—ェチルー 1, 3— O—ビス [ (3 ェチルォキセタン— 3—ィ ル)メチル] プロパン 1, 3—ジオール、 1, 4— O—ビス [ (3—ェチルォキセタン 3—ィ ル)メチル] ブタン— 1, 4ージオール、 2, 4, 6— O—トリス [ (3—ェチルォキセタン 3— ィル)メチル]シァヌル酸、ビスフエノール Aと 3—ェチルー 3—クロロメチルォキセタン(O XCと略す)のエーテル化物(BisAOX)、ビスフエノール Fと OXCのエーテル化物(Bi sFOX)、フエノールノボラックと OXCのエーテル化物(PNOX)、クレゾ一ルノボラック と OXCのエーテル化物(CNOX)、ォキセタ-ルシルセスキォキサン(OX-SQ)、 3— ェチルー 3—ヒドロキシメチルォキセタンのシリコンアルコキサイド(OX— SC)等が例示 できる。  Bis [(1-ethyl-3-oxetenyl) methyl] thiodibenzenethioether, 2,3-bis [(3-ethyloxetane-3-yl) methoxymethyl] norbornane (NDMOX), 2-ethyl 2- [( 3ethyloxetane—3yl) methoxymethyl] —1,3Obis [(1-ethyl3-oxeta-l) methyl] propane 1,3-diol (TMPTOX), 2,2 dimethyl 1,3-O— Bis [(3-ethyloxetane-3-yl) methyl] propane 1,3-diol (NPGOX), 2-butyl-2-ethyl-1,3-O-bis [(3-ethyloxetane-3-yl) methyl] Propane 1,3-diol, 1,4-O-bis [(3-ethyloxetane 3-yl) methyl] butane—1,4-diol, 2,4,6-O-tris [(3-ethyloxetane 3-di) Methyl) cyanuric acid, bisphenol A and 3-ethyl-3-chloromethyloxetane (O Etherified product of XC) (BisAOX), etherified product of bisphenol F and OXC (BisFOX), etherified product of phenol novolak and OXC (PNOX), etherified product of cresol novolac and OXC (CNOX), oxeta-lucyl Examples include sesquioxane (OX-SQ) and silicon alkoxide (OX-SC) of 3-ethyl-3-hydroxymethyloxetane.
また、特開平 8— 85775号公報および特開平 8— 134405号公報等に記載された各 種のォキセタンィ匕合物が挙げられ、これらの中でもォキセタ-ル基を 2個以上有する 化合物を用いることができる。  Further, various kinds of oxetane conjugates described in JP-A-8-85775 and JP-A-8-134405 are exemplified, and among them, a compound having two or more oxetal groups can be used. it can.
[0080] ビュルエーテル基を有する化合物 Aとしては、シクロへキサンジメタノールジビュル エーテル、トリエチレングリコールジビニルエーテルおよびノボラック型ジビニルエー テル等が挙げられる。 [0080] Examples of the compound A having a butyl ether group include cyclohexane dimethanol dibutyl ether, triethylene glycol divinyl ether, and novolak type divinyl ether.
[0081] 本発明の組成物に配合する化合物 Bとしては、エポキシ基を有する化合物 B、ォキ セタ-ル基を有する化合物 B、およびビニルエーテル基を有する化合物 Bが挙げら れ、これらの混合物を用いることもできる。  [0081] Examples of the compound B to be added to the composition of the present invention include a compound B having an epoxy group, a compound B having an oxetal group, and a compound B having a vinyl ether group. It can also be used.
化合物 Bは、本発明の組成物のカチオン重合性基を含む化合物成分 100重量部 に対して 5— 60重量部含有されていることが好ましぐ 10— 50重量部含有されてい ることがより好まし!/、。 Compound B is preferably contained in an amount of 5 to 60 parts by weight, more preferably 10 to 50 parts by weight, based on 100 parts by weight of the compound component containing a cationically polymerizable group of the composition of the present invention. Is more preferable! / ,.
[0082] エポキシ基を有する化合物 Bとしては、ビュルシクロへキセンオキサイド、 4 ビュル エポキシシクロへキサン、 1, 2—エポキシへキサデカンなどの α—才レフインェポキサ イド、フエ-ルグリシジルエーテル、 2—ェチルへキシルグリシジルエーテル、ドデシル グリシジルエーテル、グリシジルメタタリレート、エポキシへキサヒドロフタル酸ジォクチ ル、エポキシへキサヒドロフタル酸ジ 2—ェチルへキシル、脂肪族高級アルコールの モノグリシジルエーテル類;フエノール、クレゾール、ブチルフエノールまたはこれらに アルキレンオキサイドを付カ卩して得られるポリエーテルアルコールのモノグリシジルェ 一テル類;高級脂肪酸のモノグリシジルエステル類などが例示できる。  Examples of the compound B having an epoxy group include α-methyl phenylepoxide, phenylglycidyl ether, and 2-ethylhexyl, such as butylcyclohexene oxide, 4-butylepoxycyclohexane, and 1,2-epoxyhexadecane. Glycidyl ether, dodecyl glycidyl ether, glycidyl methacrylate, dioctyl epoxyhexahydrophthalate, di-2-ethylhexyl epoxyhexahydrophthalate, monoglycidyl ethers of higher aliphatic alcohols; phenol, cresol, butylphenol Or monoglycidyl ethers of polyether alcohols obtained by adding alkylene oxide thereto; monoglycidyl esters of higher fatty acids;
[0083] ォキセタニル基を有する化合物 Βとしては (カツコ内は商品名または開発品名、東 亞合成製)、 3—ェチルー 3—( 2 ェチルへキシロキシメチル)ォキセタン(ァロンォキセ タン0 丁ー212 110 ))、 3—ェチル—3— (へキシロキシメチル)ォキセタン、 3—ェ チルー 3— (シクロへキシロキシメチル)ォキセタン(CHOX)、 3—ェチルー 3— (ドデシ口 キシメチル)ォキセタン(OXR— 12)、 3—ェチルー 3 (ォクタデシ口キシメチル)ォキセ タン(OXR— 18)、 3—ェチルー 3— (フエノキシメチル)ォキセタン(ァロンォキセタン ΟΧ Τ 211 (ΡΟΧ) )、 3—ェチルー 3—ヒドロキシメチルォキセタン(ΟΧΑ)、 3—ェチル—3— (クロロメチノレ)ォキセタンなどが挙げられる。 [0083] As the compound having an oxetanyl group (Katsuko is a trade name or a developed product name, manufactured by Toagosei Co., Ltd.), 3-ethyl-3- (2-ethylhexyloxymethyl) oxetane (aronoxetane 0-212110) ), 3-Ethyl-3- (hexyloxymethyl) oxetane, 3-Ethyl-3- (cyclohexyloxymethyl) oxetane (CHOX), 3-Ethyl-3- (dodecyl xymethyl) oxetane (OXR-12) 3-Ethyl-3 (octadecoxymethyl) oxetane (OXR-18), 3-Ethyl-3- (phenoxymethyl) oxetane (Alonoxetane ΟΧ Τ 211 (ΡΟΧ)), 3-Ethyl-3-hydroxymethyloxetane (ΟΧΑ) , 3-Ethyl-3- (chloromethinole) oxetane and the like.
[0084] ビュルエーテル基を有する化合物 Βとしては、ヒドロキシェチルビ-ルエーテル、ヒ ドロキシブチノレビニノレエーテノレ、ドデシノレビニノレエーテノレ、プロぺニノレエーテノレプロ ピレンカーボネートおよびシクロへキシルビ-ルエーテル等が挙げられる。 Examples of the compound having a butyl ether group include hydroxyethyl butyl ether, hydroxybutynolebininoleatene, dodecinolebininoleatene, propeninoleatenolepropylene carbonate and cyclohexylvinyl And the like.
[0085] これらのうち、ォキセタニル基を有する化合物は、硬化性に優れるため、本発明の 組成物に好ましく配合できる。特に、ォキセタニル基を有する化合物として単官能の もの、すなわち 1分子中に 1個のォキセタ-ル基を有する化合物を用いた場合、本発 明の硬化物は密着性が困難な基材に対しても優れた密着性を示すため、このような 用途において好ましく適用できる。そのうち特に好適なものとしては、 3—ェチルー 3—( フエノキシメチル)ォキセタン(ァロンォキセタン ΟΧΤ— 211 (ΡΟΧ) )が例示できる。 [0085] Of these, compounds having an oxetanyl group are excellent in curability, and thus can be preferably added to the composition of the present invention. In particular, when a monofunctional compound having an oxetanyl group, that is, a compound having one oxetal group in one molecule, is used, the cured product of the present invention can be applied to a substrate having difficult adhesion. Can also be preferably used in such applications because they exhibit excellent adhesion. Among them, a particularly preferable example is 3-ethyl-3- (phenoxymethyl) oxetane (aronoxetane II- 211 (II)).
[0086] 本発明のカチオン硬化性の組成物には、分子中に少なくとも一個のラジカル重合 性基を有する化合物を重合成成分として配合することもできる。このようなものとして は、(メタ)アタリレート、(メタ)アクリル酸、(メタ)アクリルアミド、 N—メチロール (メタ)ァ クリルアミド、 N-メトキシメチル (メタ)アクリルアミドおよび N-メトキシブチル (メタ)ァク リルアミド等の(メタ)アタリロイル基を有する化合物;フマル酸モノブチルエステルおよ びマレイン酸モノブチルエステル等の不飽和ジカルボン酸のモノアルキルエステル および無水マレイン酸等が挙げられる。 (メタ)アタリロイル基とは、アタリロイル基とメタ クリロイル基とを示す。 [0086] In the cationically curable composition of the present invention, a compound having at least one radically polymerizable group in the molecule may be blended as a polysynthetic component. As such Are (meth) acrylates, (meth) acrylic acid, (meth) acrylamide, N-methylol (meth) acrylamide, N-methoxymethyl (meth) acrylamide and N-methoxybutyl (meth) acrylamide. Compounds having a (meth) atalyloyl group; monoalkyl esters of unsaturated dicarboxylic acids such as monobutyl fumarate and monobutyl maleate; and maleic anhydride. The (meth) atalyloyl group means an atalyloyl group and a methacryloyl group.
[0087] (メタ)アタリロイル基を有する化合物のうち、(メタ)アタリロイル基を一個有する化合 物としては、例えば N—ビュルピロリドン、並びにテトラヒドロフルフリル (メタ)アタリレー ト、 2—ェチルへキシルアタリレート、 2—ヒドロキシェチル (メタ)アタリレートおよび 2—ヒ ドロキシプロピル (メタ)アタリレート等のヒドロキシアルキル (メタ)アタリレート類、並び にフエノールのエチレンオキサイド付カ卩物等のフエノールのアルキレンオキサイド付 加物の(メタ)アタリレート類、並びにノユルフェノールのようなアルキルフエノールのェ チレンオキサイド付カ卩物等のアルキルフエノールのアルキレンオキサイド付カ卩物の(メ タ)アタリレート類、並びに 2—ェチルへキサノールのエチレンオキサイド付カ卩物の(メ タ)アタリレート等の脂肪族アルコールのアルキレンオキサイド付加物の(メタ)アタリレ ート類等が挙げられる。上記のアルキルとは、分岐があっても良い低級アルキル基で あり、具体的には、ェチルおよびプロピル等のような炭素数 1一 6のものである。また、 上記のアルキレンとは、分岐があっても良い低級アルキル基であり、具体的には、ェ チレンおよびプロピレン等のような炭素数 1一 6のものである。また、上記のアルキレン オキサイドとは、エチレンおよびプロピレンのような良い低級アルキレンよりなるもので ある。本発明のカチオン硬化性の組成物には、これらの化合物を 2種以上併用するこ とちでさる。  [0087] Among the compounds having a (meth) atalyloyl group, compounds having one (meth) atalyloyl group include, for example, N-butylpyrrolidone, tetrahydrofurfuryl (meth) atalylate, and 2-ethylhexyl acrylate Hydroxyalkyl (meth) acrylates, such as 2-hydroxyethyl (meth) acrylate and 2-hydroxypropyl (meth) acrylate, and alkylene oxides of phenol, such as phenol and ethylene oxide (Meta) acrylates of adducts, (meta) acrylates of alkyl phenols such as noyulphenol, alkylene oxides such as ketene, etc. —Ethyl hexanol with ethylene oxide And (meth) acrylates of alkylene oxide adducts of aliphatic alcohols such as atalylate. The above-mentioned alkyl is a lower alkyl group which may have a branch, and specifically, has 16 to 16 carbon atoms such as ethyl and propyl. Further, the above-mentioned alkylene is a lower alkyl group which may have a branch, and specifically, an alkylene having a carbon number of 116 such as ethylene and propylene. The above-mentioned alkylene oxides are those composed of good lower alkylenes such as ethylene and propylene. In the cationically curable composition of the present invention, two or more of these compounds are used in combination.
[0088] (メタ)アタリロイル基を有する化合物のうち、アタリロイル基を 1分子中に 2個以上有 する化合物としては、エチレンオキサイド変性ビスフエノール Fのジアタリレート(例え ば東亞合成 (株)製「ァロニックス M208」 )、エチレンオキサイド変性ビスフエノール A のジアタリレート(例えば東亞合成 (株)製「ァロニックス M210」)、プロピレンォキサイ ド変性ビスフエノール Aのジアタリレート (例えば共栄社ィ匕学 (株)製「ライトアタリレート BP— 4PA」)、エチレンオキサイド変性イソシァヌル酸のジアタリレート(例えば東亞合 成 (株)製「ァロニックス M215」)、ポリプロピレングリコールジアタリレート(例えば東亞 合成 (株)製「ァロニックス M225」)、ポリエチレングリコールジアタリレート(例えば東 亞合成 (株)製「ァロニックス M240」 )、ポリテトラメチレングリコールジアタリレート(例 えば共栄社ィ匕学 (株)製「ライトアタリレート PTMGA— 250」)、ペンタエリスリトールジ アタリレートモノステアレート(例えば東亞合成 (株)製「ァロニックス M233」)、ネオペ ンチルダリコールジアタリレート、へキサンジオールジアタリレート、ノナンジオールジ アタリレート、ジメチロールトリシクロデカンジアタリレート(例えば共栄社化学 (株)製「 ライトアタリレート DCP— A」)、トリメチロールプロパンアクリル酸安息香酸エステル(例 えば共栄社ィ匕学 (株)製「ライトアタリレート BA— 134」)、ヒドロキシビバリン酸ネオペン チルダリコールジアタリレート(例えば共栄社ィ匕学 (株)製「ライトアタリレート HPP— A」 )、ペンタエリスリトールトリアタリレート(例えば東亞合成 (株)製「ァロニックス M305」) 、トリメチロールプロパントリアタリレート(例えば東亞合成 (株)製「ァロニックス M309」 )、アルキレンオキサイド変性トリメチロールプロパントリアタリレート(例えば東亞合成 ( 株)製「ァロニックス M310」、 「ァロニックス M350」)、エチレンオキサイド変性イソシ ァヌル酸のトリアタリレート (例えば東亞合成 (株)製「ァロニックス M315」)、グリセリン トリアタリレート、アルキレンオキサイド変性グリセロールのトリアタリレート(例えば日本 化薬 (株)製「カャラッド GPO— 303」 )、ペンタエリスリトールテトラアタリレート(例えば 東亞合成 (株)製「ァロニックス M450」 )、ジペンタエリスリトールへキサアタリレート( 例えば東亞合成 (株)製「ァロニックス M400」)、ジトリメチロールプロパンテトラアタリ レート(例えば東亞合成 (株)製「ァロニックス M458」)、ウレタンアタリレート(例えば 東亞合成(株)製「ァロニックス Ml 100」、「ァロニックス M1200」、「ァロニックス M16 00」)、ポリエステルアタリレート(例えば東亞合成 (株)製「ァロニックス M6100」、「ァ 口ニックス M7100」)、アルキレングリコールジグリシジルエーテルのアクリル酸付カロ 物(例えば共栄社化学 (株)製「エポキシエステル 70PA」)、ビスフエノール Aジグリシ ジルエーテルのアクリル酸付加物(例えば昭和高分子 (株)製「リポキシ VR60」 )、フ エノールノボラック型エポキシ榭脂のアクリル酸付加物 (例えば昭和高分子 (株)製「リ ポキシ H600」)、臭素化ビスフエノール Aジグリシジルエーテルのアクリル酸付カ卩物( 例えば昭和高分子 (株)製「リポキシ SP510」)等がある。これらの化合物は所望によ り 2種類以上用いても良い。 [0088] Among the compounds having a (meth) atalyloyl group, a compound having two or more atariloyl groups in one molecule includes a diatalylate of ethylene oxide-modified bisphenol F (for example, "Aronix M208 manufactured by Toagosei Co., Ltd.) )), Diatalylate of ethylene oxide-modified bisphenol A (for example, "Aronix M210" manufactured by Toagosei Co., Ltd.), and diatalylate of propylene oxide-modified bisphenol A (for example, "Light Atarilate BP" manufactured by Kyoeisha-Danigaku Co., Ltd.) — 4PA ”), ethylene oxide-modified isocyanuric acid diatalylate (eg, Seiko Co., Ltd. “Aronics M215”), polypropylene glycol diatalylate (eg, Toagosei Co., Ltd. “Aronics M225”), polyethylene glycol diatalylate (eg, Toagosei Co., Ltd. “Aronics M240”), Polytetramethylene glycol diatalylate (for example, “Kyoeisha-Danigaku Co., Ltd.“ Light Atarilate PTMGA-250 ”), pentaerythritol di-atalylate monostearate (eg, Toagosei Co., Ltd.“ Aronix M233 ”), Neopentyldaricole diatalylate, hexanediol diatalylate, nonanediol diatalylate, dimethylol tricyclodecane diatalylate (for example, “Kyoeisha Chemical Co., Ltd.“ Light Atalylate DCP-A ”), trimethylolpropane Acrylic acid benzoate (for example, Kyoeisha Co., Ltd. "Light Atarilate BA-134"), hydroxypivalic acid neopentyl cholesteric alcohol diatalylate (for example, Kyoeisha I-Danigaku Co., Ltd. "Light Atarilate HPP-A"), pentaerythritol triatalylate ( For example, “Aronix M305” manufactured by Toagosei Co., Ltd., trimethylolpropane triatalylate (eg, “Aronix M309” manufactured by Toagosei Co., Ltd.), and alkylene oxide-modified trimethylolpropanetriatalylate (eg, manufactured by Toagosei Co., Ltd.) "Alonics M310", "Alonics M350"), ethylene oxide-modified isocyanuric acid triatalylate (eg, Toagosei Co., Ltd. "Aronics M315"), glycerin triatalylate, alkylene oxide-modified triglycerol (eg, Nippon Kayaku Co., Ltd. O-303 ”), pentaerythritol tetraatalylate (eg,“ Aronix M450 ”manufactured by Toagosei Co., Ltd.), dipentaerythritol hexaatalylate (eg,“ Aronix M400 ”manufactured by Toagosei Co., Ltd.), ditrimethylolpropanetetra Atarilate (for example, "Aronix M458" manufactured by Toagosei Co., Ltd.), urethane atarilate (for example, "Aronix Ml100", "Aronix M1200", "Aronix M1600" manufactured by Toagosei Co., Ltd.), and polyester atelylate (for example, "Aronix M6100" and "Aguchi Nicks M7100" manufactured by Toagosei Co., Ltd., carohydrates of acrylic acid of alkylene glycol diglycidyl ether (for example, "Epoxyester 70PA" manufactured by Kyoeisha Chemical Co., Ltd.), bisphenol A diglycidyl Acrylic acid adduct of ether (for example, manufactured by Showa High Polymer Co., Ltd.) Lipoxy VR60 ”), acrylic acid adduct of phenol novolak type epoxy resin (eg,“ Lipoxy H600 ”manufactured by Showa Polymer Co., Ltd.), brominated bisphenol A diglycidyl ether with acrylic acid (eg, Showa High Polymer Co., Ltd.'s "Lipoxy SP510"). These compounds are optional. Two or more types may be used.
[0089] これら以外に本発明の組成物には、カチオン重合を阻害しないものであれば、各種 モノマー、オリゴマー、ポリマー等を配合することができる。  [0089] In addition to the above, various monomers, oligomers, polymers, and the like can be added to the composition of the present invention as long as they do not inhibit cationic polymerization.
[0090] 本発明の組成物には、必要に応じて、シリカ、アルミナ、その他金属酸化物などの フィラーを配合してもよい。これにより、チクソトロピー性の付与などができる。  [0090] The composition of the present invention may optionally contain a filler such as silica, alumina, and other metal oxides. Thereby, thixotropy can be imparted.
また、電気絶縁材料として使用するときや腐食性のある基材を使用するときには、ィ オン交換能を有する材料を配合することが好ましぐさらに好ましくは無機系のもので あり、特に好ましくは陰イオン交換能を有するものである。好適な無機系陰イオン交 換体の例としては、 IXE— 500、 IXE— 530、 IXE— 550、 IXE— 700、 IXE— 800など( V、ずれも東亞合成製)が例示できる。  When used as an electrical insulating material or when a corrosive substrate is used, it is preferable to add a material having ion exchangeability, more preferably an inorganic material, and particularly preferably a negative electrode. It has ion exchange ability. Examples of suitable inorganic anion exchangers include IXE-500, IXE-530, IXE-550, IXE-700, and IXE-800 (V, the deviation is also manufactured by Toagosei).
[0091] さらに、本発明の組成物には、硬化物の無機材料への密着性の向上を目的として 、シランカップリング剤等のカップリング剤を配合することも可能である。好適なシラン カップリング剤としては、 β - (3, 4 エポキシシクロへキシル)ェチルトリメトキシシラン (信越化学製、 ΚΒΜ-303)、 γ -グリシドキシプロピルトリメトキシシラン (信越ィ匕学製 、 ΚΒΜ-403)、 γーグリシドキシプロピルトリエトキシシラン(信越化学製、 ΚΒΕ— 403 )、 γ—グリシドキシプロピルメチルジェトキシシラン (信越ィ匕学製、 ΚΒΜ— 402)、 3— ェチルー 3— { [3— (トリエトキシシリル)プロボキシ]メチル }ォキセタン (東亞合成製、 Ο XT-610)などが挙げられる。  [0091] Further, a coupling agent such as a silane coupling agent can be added to the composition of the present invention for the purpose of improving the adhesion of the cured product to an inorganic material. Suitable silane coupling agents include β- (3,4 epoxycyclohexyl) ethyltrimethoxysilane (Shin-Etsu Chemical Co., Ltd., ΚΒΜ-303), and γ-glycidoxypropyltrimethoxysilane (Shin-Etsu Rigaku Co., Ltd.) , ΚΒΜ-403), γ-glycidoxypropyltriethoxysilane (Shin-Etsu Chemical Co., Ltd., ΚΒΕ-403), γ-glycidoxypropylmethyljetoxysilane (Shin-Etsu Iridaku, ΚΒΜ-402), 3-ethylethyl 3 -— [[3- (triethoxysilyl) propoxy] methyl} oxetane (Toagosei Co., Ltd., XT-610) and the like.
[0092] 本発明の組成物には、耐熱性の向上等の目的のため、酸化防止剤を配合すること ができる。本発明の組成物に含有させる酸化防止剤としては、フエノール系酸ィ匕防止 剤、ィォゥ系酸化防止剤、リン系酸化防止剤、アミン系酸ィ匕防止剤が挙げられるが、 特に好ましいのはフエノール系酸ィ匕防止剤である。  [0092] An antioxidant can be added to the composition of the present invention for the purpose of improving heat resistance and the like. Examples of the antioxidant to be contained in the composition of the present invention include a phenolic antioxidant, a zeolite antioxidant, a phosphorus antioxidant, and an amine antioxidant, and particularly preferred are It is a phenol-based antioxidant.
[0093] フエノール系酸化防止剤としては、ハイドロキノンモノメチルエーテル、 2, 6—ジー t ブチルヒドロキシトルエン(例えば川口化学製 BHT)、 2, 2,ーメチレンビス (4ーメチ ルー 6— t ブチルフエノール)、 4, 4 'ーブチリデンビスー(3—メチルー 6— tーブチルフエノ ール)、トリエチレングリコール ビス— [3— (3,一 tーブチルー 4ーヒドロキシー 5—メチルフ ェ-ル)]プロピオネート、ペンタエリスリトールーテトラキス [3— (3, 5—ジー tーブチルー 4 —ヒドロキシフエ-ル)プロピオネート] (チノく'スペシャルティーケミカルズ社製 Irgano x 1010)、 n—ォクタデシル— 3— [ (3,, 5しジ— t—ブチルー 4,―ヒドロキシフエ-ル) プロピオネート]、 4, 4,ーチォビス(3—メチルー 6— tーブチル)フエノール、等が挙げら れる。 [0093] Examples of the phenolic antioxidants include hydroquinone monomethyl ether, 2,6-di-t-butylhydroxytoluene (for example, BHT manufactured by Kawaguchi Chemical), 2,2-methylenebis (4-methyl-6-t-butylphenol), 4, 4'butylidenebis- (3-methyl-6-t-butylphenol), triethylene glycol bis- [3- (3,1-tert-butyl-4-hydroxy-5-methylphenol)] propionate, pentaerythritol-tetrakis [3 — (3,5-di-tert-butyl-4 —hydroxyphenyl) propionate] (Tinoku's Irgano manufactured by Specialty Chemicals) x 1010), n-octadecyl-3-([3,5, di-tert-butyl-4, -hydroxyphenyl) propionate], 4,4, -thiobis (3-methyl-6-tert-butyl) phenol, etc. Are mentioned.
[0094] 本発明の組成物を、透明性の要求されない用途に用いる場合には、必要に応じて 、粉末状の補強剤や充填剤、例えば酸ィ匕アルミニウム、酸ィ匕マグネシウム等の金属 酸化物、炭酸カルシウム、炭酸マグネシウム等の金属炭酸塩、ケイソゥ土粉、塩基性 ケィ酸マグネシウム、焼成クレイ、微粉末シリカ、溶融シリカ、結晶シリカ等のケィ素化 合物、水酸化アルミニウム等の金属水酸化物、その他、カオリン、マイ力、石英粉末、 グラフアイト、二硫ィ匕モリブデン等、さらに繊維質の補強剤や充填剤、たとえばガラス 繊維、セラミック繊維、カーボンファイバー、アルミナ繊維、炭化ケィ素繊維、ボロン繊 維、ポリエステル繊維およびポリアミド繊維等を含有することができる。これらは本発 明の組成物 100重量部に対して、 10— 900重量部配合することができる。  [0094] When the composition of the present invention is used for applications where transparency is not required, a powdery reinforcing agent or filler such as metal oxides such as aluminum oxide and magnesium oxide may be used, if necessary. Substances, metal carbonates such as calcium carbonate and magnesium carbonate, diatomaceous earth powder, basic magnesium silicate, calcined clay, fine powdered silica, fused silica, crystalline silica and other metal compounds, and metal water such as aluminum hydroxide Oxides, other materials, such as kaolin, myriki, quartz powder, graphite, molybdenum disulfide, and other fibrous reinforcing agents and fillers such as glass fiber, ceramic fiber, carbon fiber, alumina fiber, and silicon carbide fiber , Boron fiber, polyester fiber, polyamide fiber and the like. These can be added in an amount of 10 to 900 parts by weight based on 100 parts by weight of the composition of the present invention.
さらに、必要に応じて着色剤、顔料、難燃剤、例えば二酸ィ匕チタン、鉄黒、モリブデ ン赤、紺青、群青、カドミウム黄、カドミウム赤、三酸ィ匕アンチモン、赤燐、ブロム化合 物およびトリフエ-ルホスフェイト等を配合することができる。これらは本発明の組成物 100重量部に対して、 0. 1— 20重量部配合することができる。  Further, if necessary, a coloring agent, a pigment, and a flame retardant, for example, titanium dioxide, iron black, molybdenum red, dark blue, ultramarine, cadmium yellow, cadmium red, antimony trioxide, red phosphorus, and a bromide compound And triphenyl phosphate and the like. These can be added in an amount of 0.1 to 20 parts by weight based on 100 parts by weight of the composition of the present invention.
[0095] さらに、成形品等における榭脂の性質を改善する目的で種々の硬化性モノマー、 オリゴマーおよび合成樹脂を本発明の組成物に配合することができる。例えば、モノ エポキシ等のエポキシ榭脂用希釈剤、フエノール榭脂、アルキド榭脂、メラミン榭脂、 フッ素榭脂、塩化ビュル榭脂、アクリル榭脂、シリコーン榭脂、ポリエステル榭脂等の 1種または 2種以上の組み合わせを挙げることができる。これら榭脂類の配合割合は 、本発明の組成物の本来の性質であるカチオン重合性を損なわない範囲の量、すな わち本発明の組成物 100重量部に対して、 50重量部以下が好ましい。  [0095] Further, various curable monomers, oligomers and synthetic resins can be added to the composition of the present invention for the purpose of improving the properties of the resin in the molded article and the like. For example, diluents for epoxy resin such as monoepoxy, phenol resin, alkyd resin, melamine resin, fluorine resin, chlorinated vinyl resin, acrylic resin, silicone resin, polyester resin, etc. Two or more combinations can be given. The mixing ratio of these resins is within a range that does not impair the cationic polymerizability, which is the original property of the composition of the present invention, that is, 50 parts by weight or less for 100 parts by weight of the composition of the present invention. Is preferred.
[0096] 本発明の組成物および任意成分の配合手段としては、加熱溶融混合、ロール、二 ーダ一による溶融混練、適当な有機溶剤を用いての湿式混合および乾式混合等が 挙げられる。 [0096] Examples of means for blending the composition of the present invention and optional components include heat-melt mixing, melt-kneading using a roll or a kneader, wet mixing using an appropriate organic solvent, and dry mixing.
[0097] 本発明の組成物は、熱カチオン重合開始剤を用いた場合は熱により、また、活性ェ ネルギ一線カチオン重合開始剤を用いた場合は活性エネルギー線で硬化される。 熱カチオン重合の場合は、通常、その熱カチオン重合開始剤がカチオン種やルイス 酸の発生を開始する温度以上で行われ、通常 50— 200°Cにて実施される。 [0097] The composition of the present invention is cured by heat when a thermal cationic polymerization initiator is used, or by an active energy ray when an active energy linear cationic polymerization initiator is used. In the case of thermal cationic polymerization, the thermal cationic polymerization initiator is usually carried out at a temperature not lower than the temperature at which the generation of cationic species or Lewis acid is started, usually at 50 to 200 ° C.
熱により重合を行う場合は一般的に知られた方法により熱を適応する事ができ、そ の条件などは特に限定されるものではな 、。  In the case of performing polymerization by heat, heat can be applied by a generally known method, and the conditions and the like are not particularly limited.
[0098] 本発明の式(1)を含有する組成物は、重合時の酸素阻害が小さいことから、少ない 活性エネルギー線 (紫外線等)照射で硬化させることができる。また、熱による重合も 同様である。 [0098] The composition containing the formula (1) of the present invention can be cured by irradiation with a small amount of active energy rays (ultraviolet rays or the like) since oxygen inhibition during polymerization is small. The same applies to polymerization by heat.
[0099] 本発明の式(1)を配合した組成物の使用方法としては、基材に組成物を塗布した 後、紫外線を照射する方法等が挙げられる。当該基材としては、ポリカーボネート、ポ リメチルメタタリレート等の成形榭脂加工品(プラスチック)、金属、ガラス、コンクリート 、 自然の木材および合成木材等の木材、石材並びに紙等が挙げられる。  [0099] Examples of the method of using the composition of the present invention in which the formula (1) is blended include a method of applying the composition to a substrate and then irradiating the composition with ultraviolet light. Examples of the substrate include molded resin products (plastics) such as polycarbonate and polymethylmethacrylate, metals, glass, concrete, wood such as natural wood and synthetic wood, stone materials, and paper.
[0100] 本発明のカチオン硬化性の紫外線硬化型組成物は、硬化後の黄変が非常に少な いため、液晶ディスプレイ、プラズマディスプレイ、タツチパネル等のディスプレイ用材 料や、光学レンズ等の、透明性を必要とする光学材料として好適に使用する事がで きる。即ち、本発明の組成物の硬化物は、光学材料に好適に用いることができる。 本発明の組成物の使用例を以下に例示する。例えば液晶ディスプレイのレンズシ 一トゃ導光板やその表面に使用できる。また、液晶ディスプレイ等のバインダーに使 用して拡散シートとして、液晶ディスプレイ等の偏向フィルム等の各種フィルムの表面 にハードコートとして、液晶ディスプレイなどの各種フィルムや基材を接着するものと して、液晶シール剤として使用することができる。また、その他の具体例を例示すると 、プラズマディスプレイゃタツチパネルの配線を被覆するものとして、ディスプレイの画 面の淵を接着するものとして、タツチパネルのドットスぺーサ一として、 DVDの基板と して、 DVDの接着剤として、 DVDのコーティング層として、光導波路のコアゃクラッド を作成するものとして、各種光学機器のレンズを作製するものとして、青色 LEDの封 止部分として、白色 LEDの封止部分として使用することができる。  [0100] The cationically curable ultraviolet-curable composition of the present invention has very little yellowing after curing, so that it can improve the transparency of display materials such as liquid crystal displays, plasma displays and touch panels, and optical lenses. It can be suitably used as a required optical material. That is, the cured product of the composition of the present invention can be suitably used for an optical material. Examples of use of the composition of the present invention are illustrated below. For example, it can be used for a lens sheet light guide plate of a liquid crystal display and its surface. It is also used as a diffusion sheet when used as a binder for liquid crystal displays, etc., as a hard coat on the surface of various films such as deflection films for liquid crystal displays, etc. It can be used as a liquid crystal sealant. Other specific examples are as follows: as a material for covering the wiring of the plasma display touch panel, as a material for bonding the edge of the display screen, as a dot spacer for the touch panel, as a DVD substrate, as a DVD substrate, Used as an adhesive for DVDs, as a coating layer for DVDs, as a core / clad for optical waveguides, as a lens for various optical devices, as a sealing part for blue LEDs, and as a sealing part for white LEDs can do.
[0101] 本発明の組成物の硬化物は、高屈折率で、硬化性、耐熱性、難燃性、機械特性に 優れている。このことから、塗料およびコーティング材、接着剤等に利用することもで きる。 [0102] <実施例 > [0101] The cured product of the composition of the present invention has a high refractive index, and is excellent in curability, heat resistance, flame retardancy, and mechanical properties. Therefore, it can be used for paints and coating materials, adhesives and the like. [0102] <Example>
以下に、実施例および比較例を示し、本発明をより具体的に説明する。ただし、本 発明は、これらの実施例によって限定されるものではない。下記に記載の%は、重量 %である。  Hereinafter, the present invention will be described more specifically with reference to Examples and Comparative Examples. However, the present invention is not limited by these examples. The percentages described below are percentages by weight.
[0103] <実施例 1 > [0103] <Example 1>
〇 2— [(3 ェチルォキセタン 3 ィル)メトキシ]ビフエ-ル(2— BPMOX)の合成 温度計、冷却器、攪拌装置および滴下漏斗を備えた 1000mlの四つ口フラスコに、 lmolの o フエ-ルフエノール、 1. 2molの 3 クロロメチルー 3—ェチルォキセタン(東 亞合成株式会社製)、 0. 02molのテトラブチルアンモ-ゥムブロミドをカ卩え、 75°C— 90°Cで攪拌しながら、 140. 3gの 48%水酸ィ匕カリウム水溶液(1. 2molに相当)を滴 下した。滴下終了後、反応液を約 110°Cに保ちながら 9時間撹拌した。反応液を室 温まで冷却した後、 250gの水を加え洗浄し、有機層と水層とに分離した。得られた 有機層を、 lOOgの水で 1回洗浄した。得られた有機層を減圧蒸留(173°C— 174°C 、 400Pa)により精製し、 2-[(3—ェチルォキセタン- 3—ィル)メトキシ]ビフエニル(下記 式(9) )を無色透明液体として 220. 7g (収率: 82%、純度: 99%)得た。  — Synthesis of 2-[(3-ethyloxetane-3-yl) methoxy] biphenyl (2-BPMOX) In a 1000 ml four-necked flask equipped with a thermometer, a condenser, a stirrer, and a dropping funnel, lmol of o-phenol was added. Rufenol, 1.2 mol of 3-chloromethyl-3-ethyloxetane (manufactured by Toagosei Co., Ltd.) and 0.02 mol of tetrabutylammonium-bromobromide were mixed together, and stirred at 75 ° C-90 ° C. A 48% potassium hydroxide aqueous solution (equivalent to 1.2 mol) was dropped. After completion of the dropwise addition, the mixture was stirred for 9 hours while maintaining the reaction solution at about 110 ° C. After the reaction solution was cooled to room temperature, 250 g of water was added for washing, and the mixture was separated into an organic layer and an aqueous layer. The obtained organic layer was washed once with 100 g of water. The obtained organic layer is purified by distillation under reduced pressure (173 ° C-174 ° C, 400 Pa), and 2-[(3-ethyloxetane-3-yl) methoxy] biphenyl (formula (9) below) is converted into a colorless transparent liquid. 220.7 g (yield: 82%, purity: 99%) was obtained.
NMR (CDC1; 270MHz) δ (ppm) : 7. 50—7. 29 (7H, m) , 7. 25—7. 02  NMR (CDC1; 270 MHz) δ (ppm): 7.50-7.29 (7H, m), 7.25-7.02
3  Three
(2H, m) , 4. 42 (2H, d, J = 6. 1Hz) , 4. 35 (2H, d, J = 6. 1Hz) , 4. 08 (2H, s ) , 1. 73 (2H, q, J = 7. 6Hz) , 0. 81 (3H, t, J = 7. 6Hz) .  (2H, m), 4.42 (2H, d, J = 6.1 Hz), 4.35 (2H, d, J = 6.1 Hz), 4.08 (2H, s), 1.73 (2H , q, J = 7.6Hz), 0.81 (3H, t, J = 7.6Hz).
[0104] [化 16] [0104] [Formula 16]
Figure imgf000029_0001
Figure imgf000029_0001
<実施例 2>  <Example 2>
〇4 [(3—ェチルォキセタン 3—ィル)メトキシ]ビフエ-ル(4 BPMOX)の合成 温度計、冷却器、攪拌装置および滴下漏斗を備えた 1000mlの四つ口フラスコに、 lmolの p-フエ-ルフエノール、 1. 5molの 3 クロロメチルー 3—ェチルォキセタン、 0. 04molのテトラブチルアンモ-ゥムブロミドをカ卩え、 90°Cで攪拌しながら、 140. 3gの 48%水酸ィ匕カリウム水溶液(1. 2molに相当)を滴下した。滴下終了後、反応液を約 110°Cに保ちながら 14時間撹拌した。その後、反応液に、 0. 3molの 3 クロロメチル 3 ェチルォキセタンおよび 0. 02molのテトラブチルアンモ-ゥムブロミドをカロえ、 反応液を約 110°Cに保ちながら更に 3時間撹拌した。この反応液を室温まで冷却し た後、 250gの水および 250gのトルエンをカ卩えて抽出し、有機層と水層とに分離した 。得られた有機層を、 250gの水で 3回洗浄した。得られた有機層を減圧下溶媒留去 し粗精製物 255gを得た。この粗精製物を減圧蒸留(192°C— 196°C、 400Pa)によ り精製し、 4 [(3 ェチルォキセタン 3 ィル)メトキシ]ビフエ-ル(下記式(10) )を白 色固体として 223. lg (収率: 83%、純度: 99%)得た。 〇4 Synthesis of [(3-ethyloxetane 3-yl) methoxy] biphenyl (4 BPMOX) In a 1000 ml four-necked flask equipped with a thermometer, a condenser, a stirrer, and a dropping funnel, 1 mol of p-phenylphenol, 1.5 mol of 3-chloromethyl-3-ethyloxetane, and 0.04 mol of tetrabutylammonium-bromobromide, while stirring at 90 ° C, 140.3 g of 48% hydroxylamine An aqueous potassium solution (corresponding to 1.2 mol) was added dropwise. After completion of the dropwise addition, the reaction solution was stirred for 14 hours while maintaining the temperature at about 110 ° C. Thereafter, 0.3 mol of 3-chloromethyl-3-ethyloxetane and 0.02 mol of tetrabutylammonium-bromobromide were added to the reaction solution, and the reaction solution was stirred for further 3 hours while maintaining the reaction solution at about 110 ° C. After the reaction solution was cooled to room temperature, 250 g of water and 250 g of toluene were dried and extracted, and separated into an organic layer and an aqueous layer. The obtained organic layer was washed three times with 250 g of water. The solvent was distilled off from the obtained organic layer under reduced pressure to obtain 255 g of a crude product. The crude product was purified by distillation under reduced pressure (192 ° C-196 ° C, 400 Pa), and 4 [(3-ethyloxetane-3-yl) methoxy] biphenyl (formula (10) below) was converted to a white solid. 223. lg (yield: 83%, purity: 99%) was obtained.
NMR (CDC1; 270MHz) δ (ppm) : 7. 57—7. 27 (7H, m) , 7. 04—6. 9  NMR (CDC1; 270MHz) δ (ppm): 7.57-7.27 (7H, m), 7.04-6.9
3  Three
8 (2H, m) , 4. 59 (2H, d, J = 6. 1Hz) , 4. 50 (2H, d, J = 6. 1Hz) , 4. 12 (2H, s) , 1. 90 (2H, q, J = 7. 6Hz) , 0. 95 (3H, t, J = 7. 6Hz) .  8 (2H, m), 4.59 (2H, d, J = 6.1 Hz), 4.50 (2H, d, J = 6.1 Hz), 4.12 (2H, s), 1.90 ( 2H, q, J = 7.6Hz), 0.95 (3H, t, J = 7.6Hz).
mp : 67. 8— 68. 3°C  mp: 67.8-68.3 ° C
[0106] [化 17] [0106] [Formula 17]
Figure imgf000030_0001
Figure imgf000030_0001
[0107] 〇組成物の調製  [0107] Preparation of composition
表 1に示す成分とその割合とで常法に従って混合し、カチオン硬化性の紫外線硬 化型組成物を調製した後、各種物性を評価した。表 1における略号は、以下の化合 物を示す。また、表 1の数値は重量部である。  After mixing the components and their proportions shown in Table 1 according to a conventional method to prepare a cationically curable ultraviolet-curable composition, various physical properties were evaluated. The abbreviations in Table 1 indicate the following compounds. The values in Table 1 are parts by weight.
YD128 :ビスフエノール A型エポキシ榭脂 (東都化成 (株)製)  YD128: Bisphenol A type epoxy resin (Toto Kasei Co., Ltd.)
OPP-G:オルトフェニルフェノールグリシジルエーテル(三光(株))  OPP-G: orthophenylphenol glycidyl ether (Sanko Co., Ltd.)
UVR6110 : 3, 4 エポキシシクロへキシルメチルー 3, 4 エポキシシクロへキサン力 ノレボキシレート 2-BPMOX:上記合成した化合物 UVR6110: 3,4 Epoxycyclohexylmethyl-3,4 Epoxycyclohexane power 2-BPMOX: Compound synthesized above
4-BPMOX:上記合成した化合物  4-BPMOX: Compound synthesized above
POX: 3—ェチルー 3— (フエノキシメチル)ォキセタン(東亞合成 (株)製、ァロンォキセ タン OXT— 211)  POX: 3-Ethyl-3- (phenoxymethyl) oxetane (Alonoxetane OXT- 211, manufactured by Toagosei Co., Ltd.)
2, 2'— BPDOX:下記式(11)で表される化合物 (東亞合成 (株)開発品)  2, 2'-BPDOX: Compound represented by the following formula (11) (Developed by Toagosei Co., Ltd.)
RSOX:下記式(12)で表される化合物 (東亞合成 (株)開発品)  RSOX: Compound represented by the following formula (12) (developed by Toagosei Co., Ltd.)
HQOX:下記式(13)で表される化合物 (東亞合成 (株)開発品)  HQOX: a compound represented by the following formula (13) (developed by Toagosei Co., Ltd.)
TMPOX:下記式(14)で表される化合物 (東亞合成 (株)開発品)  TMPOX: Compound represented by the following formula (14) (Developed by Toagosei Co., Ltd.)
A200:脂環式エポキシ基を有するアタリレート (ダイセル化学工業 (株)製、サイクロ マー A200)  A200: Athalylate having alicyclic epoxy group (Cyclomer A200, manufactured by Daicel Chemical Industries, Ltd.)
UVI-6992:トリアリールスルホ -ゥムへキサフルォロホスフェート(ダウ ·ケミカル日 本 (株)製、光力チオン重合開始剤)  UVI-6992: Triaryl sulfo-dimethylhexafluorophosphate (Dow Chemical Nippon Co., Ltd., photo-induced thione polymerization initiator)
[化 18] [Formula 18]
Figure imgf000031_0001
Figure imgf000031_0001
[化 19] [Formula 19]
Figure imgf000031_0002
[0110] [化 20]
Figure imgf000032_0001
Figure imgf000031_0002
[0110] [Formula 20]
Figure imgf000032_0001
[0112] [表 1] [0112] [Table 1]
Figure imgf000032_0002
Figure imgf000032_0002
[0113] [表 2] 比較例 1 比較例 2 比較例 3 : 比較例 4 比較例 5 [Table 2] Comparative Example 1 Comparative Example 2 Comparative Example 3: Comparative Example 4 Comparative Example 5
YD128 20 100 に-2 _。一 _; 20 j 20To YD128 20 100 - 2 _. One _; 20 j 20
POX 80 POX 80
2, 2' -BPDOX 80 !  2, 2 '-BPDOX 80!
RSOX ; 80 40 RSOX; 80 40
HQOX 40HQOX 40
UVI-6992 2 ! 2 2 : 2 2 [0114] 〇硬化物の透明性の評価 (その 1) UVI-6992 2! 2 2: 2 2 [0114] Evaluation of transparency of cured product (Part 1)
実施例 3 実施例 7および比較例 1の各組成物に紫外線を照射して硬化させたも のについて透明性の評価を実施した。即ち、 1mm厚のスライドガラスの片面に両面 テープを 2ケ所貼り付けてスぺーサ一とし、その間に組成物を載せ、上から同じスライ ドガラスで挟んで紫外線照射し、硬化させた。紫外線照射条件は、 60WZcm高圧 水銀ランプ、ランプ高さ 30cm (150mWZcm2)、照射時間 20秒であり、片面からの み照射した。参考のため、使用したスライドガラスの紫外可視吸収スペクトルを図 1に 示す。硬化後の榭脂部分の厚さは、約 0. 25mmであった。 Example 3 Transparency was evaluated for each of the compositions of Example 7 and Comparative Example 1 which were cured by irradiation with ultraviolet rays. That is, a double-sided tape was attached to one side of a 1-mm-thick slide glass to form a spacer, and the composition was placed between the two pieces of glass. The UV irradiation conditions were a 60 WZcm high-pressure mercury lamp, a lamp height of 30 cm (150 mWZcm 2 ), an irradiation time of 20 seconds, and irradiation from only one side. The UV-visible absorption spectrum of the used slide glass is shown in Fig. 1 for reference. The thickness of the cured resin portion was about 0.25 mm.
この硬化物の可視吸収スペクトルを、 2枚のスライドガラスに挟まれた状態で、参照 光側に基材等を挿入せずに測定した。測定結果を図 2 (380— 700nmの透過率ス ベクトル)および表 3 (400nm, 380nmの透過率)に示す。実施例は、比較例 1に比 ベて明らかに 400nm付近の透過率が高ぐ黄変が小さい。  The visible absorption spectrum of the cured product was measured without sandwiching a substrate or the like on the reference light side in a state of being sandwiched between two slide glasses. The measurement results are shown in Figure 2 (transmittance spectrum from 380 to 700 nm) and Table 3 (transmittance at 400 nm and 380 nm). In the example, the transmittance around 400 nm is clearly higher and the yellowing is smaller than that of the comparative example 1.
[0115] [表 3]  [0115] [Table 3]
400nm ! 380nm 400nm! 380nm
実施例 3 87 % ; 83 %  Example 3 87%; 83%
実施例 4 86 % ! 82 %  Example 4 86%! 82%
実施例 5 86 % ! 82 %  Example 5 86%! 82%
実施例 6 86 % 82 %  Example 6 86% 82%
実施例 7 88 % 83 %  Example 7 88% 83%
比較例 1 83 % ■ 77 %  Comparative Example 1 83% ■ 77%
[0116] 〇硬化物の透明性の評価 (その 2) [0116] 評 価 Evaluation of transparency of cured product (Part 2)
実施例 3および比較例 2 比較例 5の各組成物に紫外線を照射して硬化させたも のについて透明性の評価を実施した。即ち、厚さ lmmの PMMA基板の片面に両面 テープを用いて囲いを作ってスぺーサ一とし、その中に組成物を載せ、硬化面を平 滑にする目的で上から 50 μ m厚の PETフィルム(東レ (株)製ルミラー 50— T60)をラミ ネートして紫外線照射し、硬化させた。紫外線照射条件は、 60WZcm高圧水銀ラン プ、ランプ高さ 30cm (150mWZcm2)、照射時間 30秒であり、 PET側からのみ照射 した。参考のため、使用した PETフィルムの紫外可視吸収スペクトルを図 1に示す。 その後、光源力もの光を直接照射した場合の黄変性を見るために、 PETフィルムを 外して 15秒間照射した。硬化後の榭脂部分の厚さは約 0. 25mmであった。 Example 3 and Comparative Example 2 Transparency was evaluated for each of the compositions of Comparative Example 5 which were cured by irradiation with ultraviolet rays. That is, a lmm-thick PMMA substrate is enclosed on one side with double-sided tape to form a spacer, the composition is placed in it, and a 50 μm-thick layer from the top is used to smooth the cured surface. A PET film (Lumirror 50-T60, manufactured by Toray Industries, Inc.) was laminated, irradiated with ultraviolet light, and cured. The UV irradiation conditions were a 60 WZcm high-pressure mercury lamp, a lamp height of 30 cm (150 mWZcm 2 ), and an irradiation time of 30 seconds. Irradiation was performed only from the PET side. For reference, the UV-visible absorption spectrum of the PET film used is shown in FIG. Then, in order to see yellowing when directly irradiating light with a light source power, Removed and irradiated for 15 seconds. The thickness of the resin portion after curing was about 0.25 mm.
この硬化物の可視吸収スペクトルを、 PMMA基板ごと、参照光側に PMMA基板 を挿入して測定した。測定結果を図 3および図 4に示す。実施例 3は、比較例 2—比 較例 5に比べて明らかに 400nm付近の透過率が高ぐ黄変が小さい。  The visible absorption spectrum of this cured product was measured for each PMMA substrate, with the PMMA substrate inserted on the reference light side. Figures 3 and 4 show the measurement results. In Example 3, the transmittance near 400 nm is clearly higher and the yellowing is smaller than in Comparative Example 2—Comparative Example 5.
[0117] 〇塗膜の硬化性と密着性 [0117] 硬化 Curing property and adhesion of coating film
実施例 3—実施例 5、比較例 2および比較例 3の各組成物にっ 、て硬化性と密着 性の評価を実施した。  Example 3 Each of the compositions of Example 5, Comparative Example 2 and Comparative Example 3 was evaluated for curability and adhesion.
即ち、表面未処理の 50 μ m厚の PETフィルム(東レ (株)製、ルミラー 50— T60)に、 各組成物をバーコ一ターで厚さ 20 mに塗工後、 80WZcm集光型高圧水銀ラン プ(1灯)、ランプ高さ 10cmにて、コンベア速度 10mZ分または 30mZ分で 1回通過 させて紫外線照射し、硬化性 (塗膜の様子)を手触りで調べた。この硬化性の結果を 表 4に示す。表 4の硬化性は、「〇」がタックのない硬化塗膜、「△」がタックのある硬化 塗膜、「X」が液状を表す。この結果、実施例 3および 4の組成物は、実施例 5、比較 例 2および比較例 3の組成物に比べて、硬化性に優れている。なお、紫外線照射時 の雰囲気は、 20°C、 54%R. H.であった。  That is, after coating each composition on a 50 μm thick PET film (Lumirror 50-T60, manufactured by Toray Industries, Inc.) with a bar coater to a thickness of 20 m, a 80 WZcm condensing high-pressure mercury At a lamp (1 lamp) and a lamp height of 10 cm, the film was passed once at a conveyor speed of 10 mZ or 30 mZ and irradiated with ultraviolet light, and the curability (state of the coating film) was examined by touch. Table 4 shows the results of this curability. In Table 4, "〇" indicates a cured coating film without tack, "△" indicates a cured coating film with tack, and "X" indicates liquid. As a result, the compositions of Examples 3 and 4 are more excellent in curability than the compositions of Example 5, Comparative Example 2 and Comparative Example 3. The atmosphere at the time of ultraviolet irradiation was 20 ° C and 54% RH.
密着性につ!、ては、 JIS K 5400に従って碁盤目剥離試験を実施し、次のように 判定した。  Regarding the adhesiveness, a cross-cut peeling test was performed according to JIS K 5400, and the evaluation was as follows.
X: PETと紫外線硬化型榭脂との界面で全面剥離したもの  X: Fully peeled off at the interface between PET and UV-curable resin
△:一部剥離したもの  △: Partly peeled
〇:界面剥離がなぐ且つ基材ゃ塗膜の破壊がないもの  〇: No interfacial peeling and substrate ゃ No destruction of coating film
◎:界面剥離がなぐ且つ基材 (PETフィルム)が破壊されるもの 參:界面剥離がなく、且つ塗膜 (紫外線硬化型榭脂)が破壊されるもの また、硬化塗膜 (10mZ分で硬化させたもの)の屈折率をアッベ屈折計を用いて測 定した(25°C、ナトリウム D線)。  ◎: No interfacial delamination and substrate (PET film) destruction Reference: No interfacial delamination and destruction of coating film (ultraviolet curable resin) Also, cured coating film (cured in 10 mZ) ) Was measured using an Abbe refractometer (25 ° C, sodium D line).
これらの結果も表 4に示す。  Table 4 also shows these results.
[0118] [表 4] 硬化性 硬化性 密着性 屈折率 [0118] [Table 4] Curability Curability Adhesion Refractive index
( 1 0mZ分) (30mZ分)  (10mZ min) (30mZ min)
実施例 3 〇 〇 參 1 . 594  Example 3 Reference 1. 594
実施例 4 〇 〇 ◎ 1 . 578  Example 4 〇 1 1.578
実施例 5 -△- - - - -, X Δ 1 . 580  Example 5-△-----, XΔ1.580
比較例 2 〇 Δ X 1 . 587  Comparative Example 2 〇 Δ X 1.587
比較例 3 〇 · X X 1 . 57 1  Comparative Example 3 〇 X X 1.57 1
[0119] 実施例 3と比較例 3との屈折率を比べると、実施例 3の方が高い。このことは、 2個の ォキセタニル基を有する化合物より 1個のォキセタニル基を有する化合物を用いた方 が良いことを示している。また、実施例 3と実施例 4から分力るように、密着性および透 明性が良い塗膜が得られ且つ屈折率をコントロールできることを示している。 [0119] Comparing the refractive indices of Example 3 and Comparative Example 3, Example 3 is higher. This indicates that it is better to use a compound having one oxetanyl group than a compound having two oxetanyl groups. Further, as shown in Examples 3 and 4, it is shown that a coating film having good adhesion and transparency can be obtained and the refractive index can be controlled.
産業上の利用可能性  Industrial applicability
[0120] 本発明のカチオン硬化性の紫外線硬化型組成物は、硬化後の黄変が非常に少な いため、液晶ディスプレイ、プラズマディスプレイ、タツチパネル等のディスプレイ用材 料や、光学レンズ等の、透明性を必要とする光学材料として好適に使用する事がで きる。また、本発明の式 (4)で表される化合物を含有する組成物から得られた硬化物 は、高屈折率で、硬化性、耐熱性、難燃性、機械特性に優れていることから、塗料お よびコーティング材、接着剤等に利用することができる。 [0120] The cationically curable ultraviolet-curable composition of the present invention has very little yellowing after curing, so that it can improve the transparency of display materials such as liquid crystal displays, plasma displays, touch panels, and optical lenses. It can be suitably used as a required optical material. In addition, the cured product obtained from the composition containing the compound represented by the formula (4) of the present invention has a high refractive index, and is excellent in curability, heat resistance, flame retardancy, and mechanical properties. It can be used for paints, coating materials, adhesives and the like.

Claims

請求の範囲 [1] 少なくとも一種の下記式(1)で表される化合物、 2個以上のカチオン重合性基を有する化合物 Aおよび 光力チオン重合開始剤を含むことを特徴とする 紫外線硬化型組成物。 [化 1] Claims [1] An ultraviolet-curable composition comprising at least one compound represented by the following formula (1), a compound A having two or more cationically polymerizable groups, and a photoionic thione polymerization initiator. object. [Chemical 1]
(式(1)において、 R1は水素原子またはメチル基を表し、 nは 0— 20の整数を表し、 B は炭素数 1一 6のアルキル基、炭素数 1一 6のアルコキシ基、または、ハロゲン原子を 表し、 Bの置換基数 Lは 0— 5までの整数を表し、 Bの置換基数 mは 0— 4までの整数 を表し、また、 Zは下記式(2)または下記式(3)を表す。 ) (In the formula (1), R 1 represents a hydrogen atom or a methyl group, n represents an integer of 0 to 20, B represents an alkyl group having 1 to 16 carbon atoms, an alkoxy group having 1 to 6 carbon atoms, or Represents a halogen atom, the number L of substituents of B represents an integer from 0 to 5, the number m of substituents of B represents an integer from 0 to 4, and Z represents the following formula (2) or the following formula (3) Represents.)
[化 2]  [Formula 2]
Figure imgf000036_0002
Figure imgf000036_0002
(式(2)において、 R2は水素原子または炭素数 1一 6個のアルキル基を表す。 ) [化 3] (In the formula (2), R 2 represents a hydrogen atom or an alkyl group having 116 carbon atoms.)
Figure imgf000036_0003
Figure imgf000036_0003
(式(3)において、 R3は水素原子またはメチル基を表す。 ) [2] 1個のカチオン重合性基を有する化合物 Bを更に含む請求項 1に記載の組成物。 (In the formula (3), R 3 represents a hydrogen atom or a methyl group.) [2] The composition according to claim 1, further comprising a compound B having one cationically polymerizable group.
[3] 光力チオン重合開始剤力 スルホ -ゥム塩である請求項 1または 2に記載の組成物 [3] The composition according to claim 1 or 2, which is a sulfonate salt of a photoinitiated thione polymerization initiator.
[4] 請求項 1または 2に記載の組成物に紫外線を照射してなる硬化物。 [4] A cured product obtained by irradiating the composition according to claim 1 or 2 with ultraviolet rays.
[5] 請求項 3に記載の組成物に紫外線を照射してなる硬化物。 [5] A cured product obtained by irradiating the composition according to claim 3 with ultraviolet light.
[6] 硬化物が光学材料である請求項 4に記載の硬化物。 [6] The cured product according to claim 4, wherein the cured product is an optical material.
[7] 硬化物が光学材料である請求項 5に記載の硬化物。 [7] The cured product according to claim 5, wherein the cured product is an optical material.
[8] 下記式 (4)で表される化合物。 [8] A compound represented by the following formula (4):
[化 4]  [Formula 4]
Figure imgf000037_0001
Figure imgf000037_0001
(式 (4)において、 R1は水素原子またはメチル基を表し、 R2は水素原子または炭素数 1一 6個のアルキル基を表し、 nは 0— 20の整数を表し、 Bは炭素数 1一 6のアルキル 基、炭素数 1一 6のアルコキシ基、または、ハロゲン原子を表し、 Bの置換基数 Lは 0 一 5までの整数を表し、 Bの置換基数 mは 0— 4までの整数を表す。) (In the formula (4), R 1 represents a hydrogen atom or a methyl group, R 2 represents a hydrogen atom or an alkyl group having 1 to 16 carbon atoms, n represents an integer of 0 to 20, and B represents a carbon number. It represents an alkyl group of 1 to 6, an alkoxy group of 1 to 6 carbon atoms, or a halogen atom, the number of substituents of B represents an integer of 0 to 5, the number of substituents of B is an integer of 0 to 4. Represents.)
[9] 請求項 8に記載の式 (4)で表される化合物およびカチオン重合開始剤を含有する カチオン硬化性組成物。  [9] A cationically curable composition comprising the compound represented by the formula (4) according to claim 8 and a cationic polymerization initiator.
[10] アルカリの存在下、式(5)で表される化合物と式 (6)で表わされる化合物とを反応さ せることを特徴とする式 (7)で表される化合物の製造法。  [10] A method for producing a compound represented by the formula (7), which comprises reacting a compound represented by the formula (5) with a compound represented by the formula (6) in the presence of an alkali.
[化 5]  [Formula 5]
Figure imgf000037_0002
(式(5)において、 R1は水素原子またはメチル基を表し、 nは 0— 20の整数を表し、 B は炭素数 1一 6のアルキル基、炭素数 1一 6のアルコキシ基、または、ハロゲン原子を 表し、 Bの置換基数 Lは 0— 5までの整数を表し、 Bの置換基数 mは 0— 4までの整数 を表す。)
Figure imgf000037_0002
(In the formula (5), R 1 represents a hydrogen atom or a methyl group, n represents an integer of 0 to 20, B is an alkyl group having 1 to 16 carbon atoms, an alkoxy group having 1 to 6 carbon atoms, or Represents a halogen atom, the number L of substituents of B represents an integer from 0 to 5, and the number m of substituents of B represents an integer from 0 to 4.)
[化 6] [Formula 6]
Figure imgf000038_0001
Figure imgf000038_0001
(式(7)において、 R1は水素原子またはメチル基を表し、 R2は水素原子または炭素数 1一 6個のアルキル基を表し、 nは 0— 20の整数を表し、 Bは炭素数 1一 6のアルキル 基、炭素数 1一 6のアルコキシ基、または、ハロゲン原子を表し、 Bの置換基数 Lは 0 一 5までの整数を表し、 Bの置換基数 mは 0— 4までの整数を表す。) (In the formula (7), R 1 represents a hydrogen atom or a methyl group, R 2 represents a hydrogen atom or an alkyl group having 1 to 16 carbon atoms, n represents an integer of 0 to 20, and B represents a carbon number. It represents an alkyl group of 1 to 6, an alkoxy group of 1 to 6 carbon atoms, or a halogen atom, the number of substituents of B represents an integer of 0 to 5, the number of substituents of B is an integer of 0 to 4. Represents.)
PCT/JP2005/003351 2004-03-04 2005-03-01 Ultraviolet-curing composition WO2005085317A1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
KR1020067020105A KR101111372B1 (en) 2004-03-04 2005-03-01 Ultraviolet-curing composition
JP2006510668A JP4548415B2 (en) 2004-03-04 2005-03-01 UV curable composition

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP2004-060195 2004-03-04
JP2004060195 2004-03-04
JP2004060137 2004-03-04
JP2004-060137 2004-03-04

Publications (1)

Publication Number Publication Date
WO2005085317A1 true WO2005085317A1 (en) 2005-09-15

Family

ID=34921672

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2005/003351 WO2005085317A1 (en) 2004-03-04 2005-03-01 Ultraviolet-curing composition

Country Status (4)

Country Link
JP (1) JP4548415B2 (en)
KR (1) KR101111372B1 (en)
TW (1) TWI366576B (en)
WO (1) WO2005085317A1 (en)

Cited By (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005336349A (en) * 2004-05-27 2005-12-08 Toagosei Co Ltd Cationically polymerizable composition
JP2007169567A (en) * 2005-12-26 2007-07-05 Nitto Denko Corp Optical sheet, substrate for image display device, liquid crystal display device, organic el display device and solar battery
JP2008184563A (en) * 2007-01-31 2008-08-14 Nikon Corp Resin composition for high aspect ratio structure
WO2010116929A1 (en) * 2009-04-06 2010-10-14 ダイセル化学工業株式会社 Cation-polymerizable resin composition and cured product thereof
JP2012017471A (en) * 2011-09-29 2012-01-26 Nitto Denko Corp Optical sheet, substrate for image display device, liquid crystal display device, organic el display device and solar cell
WO2012173054A1 (en) * 2011-06-11 2012-12-20 東亞合成株式会社 Active-energy-ray-curable adhesive composition for plastic film or sheet
JP2013023574A (en) * 2011-07-21 2013-02-04 Jsr Corp Radiation-curable liquid resin composition for optical stereolithography, and optically shaped article obtained by photocuring the same
JPWO2012020688A1 (en) * 2010-08-12 2013-10-28 株式会社ダイセル Low moisture-permeable resin composition and cured product thereof
WO2015151782A1 (en) * 2014-03-31 2015-10-08 日東電工株式会社 Resin composition for use in optical component and optical component using same
WO2015151688A1 (en) * 2014-03-31 2015-10-08 日東電工株式会社 Resin composition for use in optical component and optical component using same
CN105384913A (en) * 2015-12-04 2016-03-09 南昌大学 Purely cationic photosensitive resin for 3D printing stereolithographic rapid prototyping, and preparation method and application thereof
WO2017221935A1 (en) * 2016-06-21 2017-12-28 株式会社Adeka Curable composition, method for producing cured product, and cured product of same
KR20190130045A (en) * 2017-07-28 2019-11-20 주식회사 다이셀 Monomer Mixture and Curable Composition Comprising the Same
JP2020200461A (en) * 2019-06-10 2020-12-17 パナソニックIpマネジメント株式会社 Ultraviolet curable resin composition, method for producing light emitting device and light emitting device
WO2023132249A1 (en) * 2022-01-04 2023-07-13 三井化学株式会社 Resin composition for lens, cured product for lens, and lens

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102248518B1 (en) 2017-12-27 2021-05-04 주식회사 엘지화학 Photopolymerizable composition for forming bezel pattern, method of manufacturing bezel pattern using the same, and bezel pattern prepared by using the same

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60184071A (en) * 1984-02-29 1985-09-19 Dai Ichi Kogyo Seiyaku Co Ltd Glycidyl ether compound of hexabromo-p-phenylphenol
JPH0497887A (en) * 1990-08-16 1992-03-30 Oji Paper Co Ltd Thermal recording material
JP2002194056A (en) * 2000-12-27 2002-07-10 Nippon Kayaku Co Ltd Epoxy resin composition and its cured product
JP2003138006A (en) * 2001-10-31 2003-05-14 Toagosei Co Ltd Energy ray-curable composition
JP2003313271A (en) * 2002-04-19 2003-11-06 Toagosei Co Ltd Active energy ray-curable resin composition

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3508502B2 (en) * 1997-09-30 2004-03-22 宇部興産株式会社 Biphenyl derivative having oxetane ring
JP4380043B2 (en) * 2000-09-06 2009-12-09 東亞合成株式会社 Methylene bisphenol derivative mixture having oxetane ring
JP2003335765A (en) * 2002-05-20 2003-11-28 Nippon Kayaku Co Ltd Fluorine atom-containing polyfunctional oxetane compound, resin composition using the same, coating agent for optical fiber and cured product

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60184071A (en) * 1984-02-29 1985-09-19 Dai Ichi Kogyo Seiyaku Co Ltd Glycidyl ether compound of hexabromo-p-phenylphenol
JPH0497887A (en) * 1990-08-16 1992-03-30 Oji Paper Co Ltd Thermal recording material
JP2002194056A (en) * 2000-12-27 2002-07-10 Nippon Kayaku Co Ltd Epoxy resin composition and its cured product
JP2003138006A (en) * 2001-10-31 2003-05-14 Toagosei Co Ltd Energy ray-curable composition
JP2003313271A (en) * 2002-04-19 2003-11-06 Toagosei Co Ltd Active energy ray-curable resin composition

Cited By (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005336349A (en) * 2004-05-27 2005-12-08 Toagosei Co Ltd Cationically polymerizable composition
JP2007169567A (en) * 2005-12-26 2007-07-05 Nitto Denko Corp Optical sheet, substrate for image display device, liquid crystal display device, organic el display device and solar battery
JP2008184563A (en) * 2007-01-31 2008-08-14 Nikon Corp Resin composition for high aspect ratio structure
WO2010116929A1 (en) * 2009-04-06 2010-10-14 ダイセル化学工業株式会社 Cation-polymerizable resin composition and cured product thereof
JP2010241959A (en) * 2009-04-06 2010-10-28 Daicel Chem Ind Ltd Cationically polymerizable resin composition and cured product thereof
JPWO2012020688A1 (en) * 2010-08-12 2013-10-28 株式会社ダイセル Low moisture-permeable resin composition and cured product thereof
JP5812993B2 (en) * 2010-08-12 2015-11-17 株式会社ダイセル Low moisture-permeable resin composition and cured product thereof
WO2012173054A1 (en) * 2011-06-11 2012-12-20 東亞合成株式会社 Active-energy-ray-curable adhesive composition for plastic film or sheet
JP2013023574A (en) * 2011-07-21 2013-02-04 Jsr Corp Radiation-curable liquid resin composition for optical stereolithography, and optically shaped article obtained by photocuring the same
JP2012017471A (en) * 2011-09-29 2012-01-26 Nitto Denko Corp Optical sheet, substrate for image display device, liquid crystal display device, organic el display device and solar cell
JP2015194546A (en) * 2014-03-31 2015-11-05 日東電工株式会社 Optical component resin composition and optical components produced using the same
JP2015194547A (en) * 2014-03-31 2015-11-05 日東電工株式会社 Optical component resin composition and optical components produced using the same
WO2015151688A1 (en) * 2014-03-31 2015-10-08 日東電工株式会社 Resin composition for use in optical component and optical component using same
WO2015151782A1 (en) * 2014-03-31 2015-10-08 日東電工株式会社 Resin composition for use in optical component and optical component using same
CN105934690A (en) * 2014-03-31 2016-09-07 日东电工株式会社 Resin composition for use in optical component and optical component using same
CN105384913A (en) * 2015-12-04 2016-03-09 南昌大学 Purely cationic photosensitive resin for 3D printing stereolithographic rapid prototyping, and preparation method and application thereof
JPWO2017221935A1 (en) * 2016-06-21 2019-04-11 株式会社Adeka Curable composition, method for producing cured product, and cured product thereof
WO2017221935A1 (en) * 2016-06-21 2017-12-28 株式会社Adeka Curable composition, method for producing cured product, and cured product of same
JP7071262B2 (en) 2016-06-21 2022-05-18 株式会社Adeka Curable composition, method for producing cured product, and cured product thereof
KR20190130045A (en) * 2017-07-28 2019-11-20 주식회사 다이셀 Monomer Mixture and Curable Composition Comprising the Same
KR102084463B1 (en) 2017-07-28 2020-03-04 주식회사 다이셀 Monomer Mixture and Curable Composition Comprising the Same
JP2020200461A (en) * 2019-06-10 2020-12-17 パナソニックIpマネジメント株式会社 Ultraviolet curable resin composition, method for producing light emitting device and light emitting device
JP7554992B2 (en) 2019-06-10 2024-09-24 パナソニックIpマネジメント株式会社 Ultraviolet-curable resin composition, method for manufacturing light-emitting device, and light-emitting device
WO2023132249A1 (en) * 2022-01-04 2023-07-13 三井化学株式会社 Resin composition for lens, cured product for lens, and lens

Also Published As

Publication number Publication date
JPWO2005085317A1 (en) 2008-01-17
TW200609262A (en) 2006-03-16
JP4548415B2 (en) 2010-09-22
TWI366576B (en) 2012-06-21
KR101111372B1 (en) 2012-03-13
KR20070012386A (en) 2007-01-25

Similar Documents

Publication Publication Date Title
WO2005085317A1 (en) Ultraviolet-curing composition
WO2012002028A1 (en) Curable resin composition
WO2008029893A1 (en) Liquid crystal sealing agent, method for manufacturing liquid crystal display panel using the liquid crystal sealing agent, and liquid crystal display panel
TW200940604A (en) Organosilicon compounds which have oxetanyl groups, and a method for the production and curable compositions of the same
WO2017159637A1 (en) Epoxy compound, curable composition, cured product, method for producing epoxy compound, and reactive diluent
TW201802176A (en) Epoxy compound, curable composition containing this, and cured product of curable composition
JP2005336349A (en) Cationically polymerizable composition
US20230331688A1 (en) Diepoxy compound, curable composition, cured product, and optical member
CN100462385C (en) Ultraviolet-curing composition
JP6691855B2 (en) Curable composition and cured product obtained by curing the same
JP4251138B2 (en) Curing accelerator for cationic polymerization type composition
JP2012177038A (en) Epoxy resin composition
US7612123B2 (en) Cyclohexene oxide compound having cyclohexyl group or long-chain alkyl group, and use thereof
JP4873203B2 (en) Method of curing curable oxetane composition
JP5642930B2 (en) Liquid curable composition and cured product thereof
JP2008297271A (en) Oxetane compound and curable composition
JP4760827B2 (en) 1,3-propanediol derivative having oxetane ring
WO2017213205A1 (en) Epoxy compound, curable composition containing this, and cured product of curable composition
JP4352862B2 (en) Cycloaliphatic compounds having an oxetane ring
JP4910871B2 (en) Epoxy resin composition and transparent composite sheet
JP2019189789A (en) Adhesive composition for thin film, laminate using the same, and manufacturing method of laminate
WO2023145580A1 (en) Diepoxy compound, curable composition, cured product, and optical member
JP2005336333A (en) Actinic radiation curing composition
TW201630878A (en) Sulfonium borate salt, acid generating agent and curable composition
JP2002265560A (en) Novel epoxy compound and active energy ray-curable epoxy resin composition therefrom

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SM SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 200580006680.7

Country of ref document: CN

NENP Non-entry into the national phase

Ref country code: DE

WWW Wipo information: withdrawn in national office

Country of ref document: DE

WWE Wipo information: entry into national phase

Ref document number: 1020067020105

Country of ref document: KR

WWP Wipo information: published in national office

Ref document number: 1020067020105

Country of ref document: KR

122 Ep: pct application non-entry in european phase
WWE Wipo information: entry into national phase

Ref document number: 2006510668

Country of ref document: JP